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African Americans (AA) are more susceptible to end-stage renal disease (ESRD) for several 
reasons. Treatment options for patients with ESRD include dialysis therapy and transplantation, 
with the latter typically producing better outcomes. AA are less likely to complete the medical 
evaluation process, which requires patients to consult with doctors and undergo a series of tests 
and examinations. This study sought to determine the factors that predict completion of the 
medical evaluation for AA ESRD patients using a mixed methods design. Participants consisted 
of transplant professionals (N=23) recruited from nine transplant centers in the Mid-Atlantic, 
Mid-Western and Southeastern parts of the United States, and kidney patients (N=30 patients) 
  
recruited from one transplant center in the Mid-Atlantic region. Semi-structured interviews and 
nominal focus groups were conducted to gather qualitative data; quantitative survey data were 
also collected. The results revealed factors classified as impacting patients at the individual-level 
and systemic level, and others classified as health-related and informational/educational. 
Participants ranked insurances issues, limited income, lack of a personal means of transportation, 
lack of patient motivation, the number of procedures required to complete the evaluation, 
scheduling difficulties and time constraints as top barriers to completing the medical evaluation 
process. Top motivators consisted of informational support, social support, religious beliefs, 
patients’ desire to get off dialysis, support from the transplant staff, center-based education, 
patient’s knowledge of the benefits of transplantation and patient navigators. These findings 
provide valuable information on factors that impact AA renal patients’ completion of the medical 
evaluation.   
 
 
 
 
 
 
 1 
 
Factors Predicting African American Renal Patients’ Completion of the Medical Evaluation 
Process for Kidney Transplantation 
African Americans are more susceptible to end-stage renal disease (ESRD) as a result of 
genetic characteristics and socioeconomic factors such as higher rates of hypertension and 
diabetes, both leading causes of kidney disease, differences in antigens (substances which 
activate the production of antibodies), income differences and health behaviors (Andrews et al., 
2012; Churak, 2005; Ladin, Rodrigue & Hanto, 2009). According to the United States Renal Data 
System (USRDS, 2015), the incidence rate of ESRD was 3 times higher among African Americans 
relative to Caucasians in 2013. The prevalence rate of ESRD continues to be highest among 
African Americans at 5,584 per million population compared to Whites and Asians at 1,499 and 
2,196 per million population respectively (USRDS, 2015). According to the Organ Procurement 
and Transplantation Network (OPTN) there are 108, 258 patients in the US on the waitlist in the 
hopes of receiving a kidney as of April 1, 2016 (OPTN, 2016). Of the total number of patients on 
the waitlist, 36, 456 (33.68%) are African Americans, although they consist of about 13.3% of 
the US population (OPTN, 2016; United States Census Bureau, 2016). This disparity in 
incidence is also mirrored in the treatment options pursued by African American patients relative 
to Caucasians and patients from other racial and ethnic groups.  
Treatment options for patients with ESRD include dialysis therapy (i.e., hemodialysis, 
peritoneal dialysis) and transplantation, with the latter typically producing better outcomes. 
ESRD patients who receive transplants experience less mortality and morbidity and have a better 
quality of life in comparison to those who remain on dialysis (Christensen & Ehlers, 2002). 
USRDS (2013) data shows that adjusted rates for all-cause mortality for dialysis patients are 6.5 
to 6.9 times greater than the general population.  In contrast, transplant patients’ adjusted rates 
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for all-cause mortality are 1.0 to 1.5 times higher than the general population, indicating 
significant benefits of transplantation (USRDS, 2013).    
Yet, research comparing African Americans to other ethnic groups indicate lower rates of 
transplantation. One explanation is that African Americans are less likely to donate organs than 
are individuals of other races/ethnicities (Lunsford et al., 2006) which causes a disparity in the 
number of African Americans receiving kidneys relative to other groups. Although there is an 
increased need within the African American community, African Americans are less likely to 
seek kidney transplantation or complete the medical evaluation for placement on a waitlist for a 
transplantable kidney. Alexander and Sehgal (2001) noted that 84% of Blacks expressed a lack of 
interest in transplantation and/or were medically unsuitable for kidney transplantation relative to 
74% of Whites. Garg, Diener-West and Powe (2001) also reported lower rates of waitlist 
placement for Blacks relative to White renal patients. This disparity in placement on the waitlist 
appeared to be greatest among younger African Americans and African Americans with fewer 
health concerns, who were 50% and 40% less likely to be waitlisted, a finding contrary to 
previous findings. However, access to kidney transplantation involves the completion of several 
procedural steps not the least of which is a medical evaluation.  
The medical evaluation or pre-transplant work up, which requires patients to consult with 
doctors and undergo a series of tests and examinations (e.g., chest x-ray, dental exam, cancer 
screenings, etc.), is a tedious process and one that often impedes a patient’s ability to be placed 
on the waitlist. For some patients, the medical evaluation process may be the first time they learn 
about transplantation (Gaston et al., 2003). Successful completion of the medical evaluation 
generally leads to transplant candidacy status and placement on the waitlist for a deceased donor 
transplant or a living donor transplant in cases where the patient has identified a living donor 
 3 
 
(Weng, Joffe, Feldman, & Mange, 2005). Low rates of completion of the medical evaluation 
could contribute to reduced access to transplantation among African American patients with 
ESRD (Weng et al., 2005). As a result, these patients must endure sustained dialysis treatments, 
which are associated with decreased quality of life, greater dependence on health care providers, 
diet restrictions and depression (Christensen & Ehlers, 2002). Alexander and Sehgal (2001) 
advocate for reducing barriers during the early steps in the transplant process such as referral and 
evaluation in an effort to reduce racial disparities in access to transplantation. An exploration of 
the factors that promote and/ or impede the completion of the medical evaluation process is 
central to diminishing disparities in access to transplantation between African Americans and 
other racial groups such as Whites and Asians.  
Several studies have been conducted in an effort to understand why some African 
American ESRD patients complete the medical evaluation process, while the majority are unable 
to do so. Past research attributes patient and healthcare related factors including physician 
recommendation, socioeconomic status (SES), social support and physician beliefs to racial and 
ethnic differences in completion of the medical evaluation for transplantation (see Dageforde, 
Box, Feurer & Cavanaugh, 2015; Joshi, Gaynor, & Ciancio, 2012; Navaneethn & Singh, 2006). 
Given that an examination of the past literature indicates a myriad of factors contributing to 
racial differences in executing a pre-transplant work up, the current study examined the factors 
that impact medical evaluation completion specifically, the barriers and motivators to completing 
the medical evaluation. This study sought to address this phenomenon by examining the 
perceptions of transplant center professionals and ESRD patients regarding the factors that 
promote and/or hinder completion of the medical evaluation for kidney transplantation among 
African American renal patients.  
 4 
 
Literature Review 
End stage renal disease (ESRD) 
Chronic kidney disease (CKD) occurs when the kidneys fail to filter the blood properly, 
allowing waste products such as excess water and ammonium to build up in the body; the result 
is a multitude of health problems including high blood pressure, fluid in the lungs and kidney 
failure (Centers for Disease Control and Prevention (CDC), 2014). Risk factors for CKD include 
high blood pressure, diabetes, cardiovascular disease, high cholesterol, lupus and a family history 
of CKD. People with CKD are susceptible to kidney failure or ESRD (also referred to as Stage 5 
CKD), a life-threatening disease (CDC, 2014). Some of the symptoms associated with this 
disease include appetite loss, nausea, weight loss, muscle cramps, problems urinating, difficulties 
concentrating, and sleep problems (CDC, 2014).  The leading causes of kidney failure are 
diabetes and hypertension, accounting for 7 of the 10 new cases of ESRD (CDC, 2014). African 
Americans are more likely to develop ESRD than Whites which can be accounted for in part by 
the higher prevalence of hypertension and diabetes in this population (Klag, et al., 1997; Martins, 
Tareen & Norris, 2002). Blacks are also more likely to receive an HIV/AIDS diagnosis which 
could cause kidney disease, increasing a person’s likelihood of developing ESRD (Martins et al., 
2002). Black patients tend to develop ESRD at a younger age and incidence rates increase by 
age, every ten years of life. They also have the highest rate of hypertension-related ESRD, 
surpassing any other racial or ethnic group (Martins et al., 2002). Nonetheless, there are effective 
treatments for ESRD with good outcomes.  
Treatments for ESRD   
Dialysis therapy and kidney transplantation are necessary for survival when diagnosed 
with ESRD (CDC, 2014). Dialysis therapy involves the use of an artificial replacement where 
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blood is pumped from the body into a filtration device. This device cleans the blood by removing 
waste, excess fluid and toxins (USRDS, 1999). Hemodialysis is one form of dialysis treatment 
where the patient is connected to a machine which filters waste and water through the circulation 
of blood, through an artificial dialyzer also referred to as an “artificial kidney.” The cleaned 
blood is then pumped back into the patient’s body (Center for Medicare & Medicare Services 
(CMS), 2016; USRDS, 1999). Treatments are typically scheduled three times a week and could 
last for three to four hours (USRDS, 1999). Peritoneal dialysis is another form of dialysis 
treatment which requires the placement of a catheter into the abdominal cavity and is 
accompanied with repeated instillation and drainage of sterile dialysate (cleansing fluid which 
removes toxins from the bloodstream) (USRDS, 1999). Both peritoneal and hemodialysis may be 
performed at home after a patient and an assistant undergo weeks of training. However, 
hemodialysis is typically carried out in dialysis centers (USRDS, 1999). Finally, hemofiltration 
which is synonymous to hemodialysis, is used for emergency purposes (Ledebo, 1998). Past 
literature indicates that dialysis patients are more likely to be in danger of five-year mortality and 
tend to have a poorer quality of life as compared to patients who undergo transplantation 
(Waterman et al, 2006; USRDS, 2015).  
Kidney transplantation is the preferred treatment option for ESRD given that it is 
associated with reduced mortality and morbidity relative to dialysis treatments (Patzer et al., 
2009; Waterman Rodrigue, Purnell, Ladin & Boulware, 2010). The United Network for Organ 
Sharing (UNOS) 2012 annual data report for kidneys show ongoing improvements for transplant 
recipients over the last 15 years (OPTN/SRTR, 2014), including a decrease in graft failure and 
an increase the number of people living after receiving a transplant. As of June 2011, 164, 200 
adults in the US survived with a functioning kidney graft which is about twice the rate of 
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survival rate ten years ago (OPTN/SRTR, 2014). There are two forms of kidney transplantation: 
live donor kidney transplantation and deceased donor kidney transplantation. Regardless of the 
route to transplantation chosen, patients risk organ rejection, lifetime use of immunosuppressant 
mediations and surgical complications (Serur et al., 2011).  
Live donor kidney transplantation (LDKT) occurs when a kidney is donated from a 
healthy person, usually a living family member, friend or another altruistic person (Waterman et 
al., 2010). LDKT is associated with higher organ survival, better renal function and shorter wait 
times, especially since a live donor transplantation can be arranged in three to four months 
(Gruessner & Benedetti, 2008; Waterman et al., 2010). Patients are less knowledgeable of 
LDKT, hesitant to discuss this option of transplantation with potential donors, and have concerns 
about the risks associated with donation, limiting the number of living donor transplants 
performed each year (Pradel, Mullins, Bartlett, 2003; Cabrer et al., 2003; Lunsford et al., 2006; 
Traino 2014).  
Deceased donor transplantation, also referred to as cadaveric or posthumous 
transplantation, occurs after a donor’s organs are procured and evaluated for transplantation, 
after the person is pronounced brain dead or after the person’s heart is no longer beating 
(MacPhee & Fronek, 2012). The benefits of deceased donor transplantation include better quality 
of life without having to depend on a machine for survival, and it does not involve the use of a 
live donor.  
Deceased donor transplantation requires access to a transplant wait list (Gaston et al., 
2003). There has been a historic scarcity of deceased donor organs including kidneys, due to 
high demands and limited organs made available for transplantation. The median time for 
patients who were enrolled on the waitlist in 2009 was 3.6 years. In 2008, 51% of African 
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Americans remained on the waitlist after three years in comparison to 36% of Caucasians 
(USRDS, 2013, 2015).  Although there are about 108, 258 renal patients on the waitlist in hopes 
of receiving a transplantable kidney, only 1,447 transplants have been performed this year. 
African American transplant recipients make up a small fraction of this number given that only 
390 (26.95%) African American patients have received transplantable kidneys (OPTN, 2016).  
Pre-transplant Medical Evaluation  
 Placement on the transplant waitlist requires patients to meet certain criteria and complete 
numerous tests to assess transplant suitability. The medical evaluation for transplantation aims to 
identify contraindications that would preclude transplantation and to make rectifications where 
necessary in order to maximize a patient’s odds of a successful transplant (Gruessner & 
Benedetti, 2008).  The pre-transplant work up also provides an opportunity to educate the patient 
about the transplantation process given that the potential recipient meets and interacts with 
several members of the transplant team (Gruessner & Benedetti, 2008). The first part of the 
medical evaluation begins with consultations and interviews with a number of transplant 
professionals such as nephrologists, transplant coordinators, social workers although there may 
be a few variations depending on the transplant center (Gruessner & Benedetti, 2008; Ortiz, 
Manzarbeitia & Zaki 2002). 
The purpose of the consultation is to gather a comprehensive history and provide a 
physical examination. An emphasis is placed on the etiology of the progression of the disease, 
the amount of time spent on dialysis, vascular access history and problems, urine production, and 
the occurrence of urologic issues such as neurogenic bladder (a condition which causes a person 
to lose control of their bladder). Additional emphasis is placed on medications and an 
examination of systems to detect unique extrarenal organ system complications (Ortiz et al., 
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2002). Furthermore, the patient’s ability to tolerate exercise as well as discussions about how 
previous infections may compromise the transplantation are addressed (MacPhee & Fronek, 
2012). Laboratory testing, x-rays and other procedures are also performed. Some of the required 
tests include human leukocyte antigen (HLA; proteins found on white blood cells that help a 
person’s immune system detect differences between healthy body tissues and foreign 
substances); blood typing to match a kidney to the transplant candidate; chest x-rays; coagulation 
screens; mammograms for women over 40 years old; and, electrocardiograms (EKG) (Gruessner 
& Benedetti, 2008; MacPhee & Fronek, 2012). Immunizations for Hepatitis B, influenza, and 
among others are updated as needed (Gruessner & Benedetti, 2008). 
Psychosocial evaluations are performed where a social worker evaluates prospective 
candidates who are then referred to a psychologist or psychiatrist if significant psychological 
concerns come to light (McGrath & Rubin, 2012). Additionally, extensive laboratory, radiologic 
and specialty tests (e.g., endoscopy, colectomy, and liver biopsy) are performed (McGrath & 
Rubin, 2012). Elderly patients are presented with separate challenges since they are more likely 
to develop infections and malignancy may be prevalent, reducing their overall life expectancy 
(MacPhee & Fronek, 2012). Patients with comorbidities face additional challenges since this 
increases the number of tests needed to complete the evaluation (Danovitch, Cohen & Smits, 
2004). After completing this process, the patient’s information and tests are reviewed by a 
multidisciplinary team who determine whether the patient is suitable for placement on the 
national waitlist. The patient must also be financially cleared (Ortiz et al., 2002). The pre-
transplant process could take up to a year to complete with recent studies indicating that patients 
have a median referral to listing time anywhere from 46 days to 226 days (Norris, 2014). Racial 
differences in completing the medical evaluation process are evident indicating Blacks are less 
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likely to complete the process or take longer to complete the process in comparison to Whites 
(Alexander, Ashwini & Sehgal, 1998; Patzer et al., 2012). 
African Americans and Kidney Transplantation  
Several studies have investigated African American beliefs and health behaviors 
surrounding kidney transplantation. A plethora of reasons account for the problems this racial 
group faces in accessing renal transplantation. One major reason for the inequality in the pursuit 
of kidney transplantation is lower rates of organ donation among Blacks which could be 
influenced by several factors such as a lack of awareness, attitudes towards donation and medical 
mistrust (Churak, 2005; Moore, 2007; Whaley, 2001). Immunological incompatibility of 
deceased donor kidneys, lower rates of referral, limited access to healthcare, less desire for 
kidney transplantation, and socioeconomic factors such as health insurance, (see Boulware et al., 
2005; Hall, Choi, Xu, O’Hare & Chertow, 2011; Held, Pualy, Bovbjerg, Newmann & 
Salvatierra, 1988) also influence patients’ desire to seek or attain transplantation. These barriers 
may occur during different components of the transplantation process including the medical 
evaluation.  
Organ donation among Blacks  
           Blacks display lower rates of organ donation relative to other racial groups (Ariola, 
Perryman & Doldren, 2005; Ariola, Perryman, Doldren, Warren & Robinson, 2007; Held et al., 
1988). Moore (2007) reported that when families are approached to donate organs or tissues of 
their death relatives, African American families are less likely to respond. OPTN data indicates 
that of the 767 deceased donor kidneys donated in 2016, 126 were from African Americans in 
comparison to 511 from Whites. Similarly, fewer living donor kidney organs were donated from 
African Americans (32 of 425 total organs) relative to Whites (310 out of 425) (OPTN, 2016). At 
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first glance these statistics may lead one to believe that African Americans are less altruistic than 
other racial groups, particularly Whites. However, past studies indicated that African Americans 
are very charitable and contribute a larger percentage of their income to charities and churches in 
comparison to Caucasians (Moore, 2007). This suggests that other factors may account for the 
low organ donation rates among Blacks. The difference in organ donation could be attributed to 
lack of knowledge about the need for organs, attitudes and distrust of the medical system, 
concerns about the fairness of the allocation system, religious beliefs including certain 
misconceptions and socioeconomic factors such as problems with insurance. These reduced 
donation rates could contribute to the health disparities in obtaining kidney transplants (Ariola et 
al., 2005).  
           Many Blacks are unaware of the growing need for renal organs in the African American 
community. Blacks are also less likely to know someone who has donated an organ or signed up 
to become a donor (see Churak, 2005; Joshi et al., 2012). Moore (2007) highlighted the 
importance of increasing awareness of the need for organs in the African American community 
given that the lack of awareness places African Americans at a disadvantage for life saving 
treatments. Results from study of 311 African American adults whose attitudes towards organ 
donation were examined indicated that people who engaged in family discussions about donation 
were more knowledgeable of organ donation and had more favorable attitudes towards donation 
(Morgan, 2004).  This suggests that one reason for the low rates of donation among African 
Americans is a lack of awareness of the need. Therefore, increasing awareness among this 
population could result in better donation rates.  
          A number of common misconceptions about donation could also account for the disparities 
in donation among Blacks and Whites. For example, many Blacks believe that signing the donor 
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card would result in reduced medical care and an early declaration of death without provision of 
all the medical help available (Ariola et al., 2005). This could be a result of a general distrust of 
the medical community. Mistrust of the medical system and health care professionals by Blacks 
may be attributed to the historical exploitation of Blacks such as the sterilization of African 
American women and abuse during hospitalization (Churak, 2005). One of the most popular 
examples of the exploitation of Blacks is during the Tuskegee Syphilis study in which 
researchers funded by the federal government withheld treatment from the African American 
male participants (Boulware, Cooper, Ratner, Laveist & Powe, 2003). Consequently, African 
Americans who are aware of historic events of discrimination and/or have personal accounts of 
exploitation in the healthcare system are more likely to be wary of the medical community 
(Corbie-Smith, Thomas, Williams & Moody-Ayers, 1997). Previous studies found out that 
Blacks who are suspicious of Whites may terminate psychotherapy because they think they will 
be seen by a White counselor, and they perceive the healthcare facility to be governed by Whites 
(Terrell & Terrell, 1984). Many Blacks do not trust that doctors have their best interests in mind 
and as a result avoid routine checkups (Churak 2005; Moore, 2007). Terrell and colleagues 
(2004) found that Blacks who are suspicious of Whites are less willing to consent to either 
donating their own organs or agreeing to the recovery of organs from relatives (Terrell, Mosley, 
Terrell & Nickerson, 2004).  An analogous study found that Blacks who were distrustful of 
hospitals and had concerns about discrimination explained some of the variability in willingness 
to donate (Boulware et al., 2002). This distrust of the medical system is likely to impede access 
to kidney transplantation since African Americans may believe doctors do not have their best 
interest in mind. Hence, they may be hesitant to complete the pre-transplant work up since this 
 12 
 
would mean more interactions with doctors and with an increasingly complex and confusing 
healthcare system.  
Factors that impact access to kidney donation 
        Organ allocation and matching also have roles in African American views on kidney 
transplantation. Some African Americans are skeptical about donation due to apprehensions 
about race and class-based inequalities in the distribution of organs (Ariola et al., 2005) which 
could be a result of the uncertainty that the health care system is working in their favor. The 
current allocation system gives priority to people in the same geographic region versus those 
most in need. Posthumous transplantation generally favors patients living in closest proximity to 
the transplant center, which suggests that waitlisted candidates living farthest from transplant 
centers are less likely to receive a transplant (Axelrod et al., 2010). Universal criteria for 
candidate selection have yet to be established hence, individual transplant centers create their 
own medical criteria. This increases the chances that a patient who is listed at one center may be 
regarded as less critical at another center with more rigorous medical criteria (Moore, 2007).  
           Biological factors such as immunological incompatibility also result in lower rates of 
kidney transplantation among Blacks (Boulware et al., 2005). Organ allocation practices take 
into consideration certain biological characteristics of both the recipient and the donor to 
enhance graft survival. Differences in the expression of HLA antigens are more likely to occur 
among people with different racial backgrounds. Therefore, the organ allocation system attempts 
to match patient recipients to donors with similar expressions of HLA antigens (i.e., the same 
racial and ethnic background). Although this practice is less emphasized in recent years due to 
the introduction of improved immunosuppressants, recipients and donors must still possess 
significant biological similarities. Therefore, since most of the transplantable kidneys available 
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are from White donors, this reduces matching rates for Blacks (Churak, 2005; Joshi et al., 2012). 
Racial differences in ABO blood type indicate that African Americans are more likely to have 
blood type O which places them at a disadvantage since this blood type has a reduced likelihood 
of kidney transplantation according to UNOS requirements for ABO identity between donor and 
recipient (Churak, 2005), resulting in longer wait times. OPTN data shows that between 2003-
2004, the median wait time for African Americans waiting for a kidney was about 1831 days (5 
years). This varied for Whites who had a median wait time of 1310 days (3.5years) (OPTN, 
2016). Arguably, knowledge of the potential drawbacks to procuring a transplantable organ 
based on an individual’s racial status may prevent Blacks from pursuing transplantation as a 
treatment option, and prevent people from donating their kidneys.  
            Religious beliefs regarding the desecration of the body and a desire to keep the human 
body in good condition for the afterlife also impact African Americans’ attitudes toward organ 
donation (Ariola et al., 2005; Held et al., 1988). This belief system could be attributed to Judeo-
Christian religious attitudes which state that the body must be kept whole on judgment day 
(Moore, 2007).  Boulware and colleagues (2002) found that spirituality and religion accounted 
for most of the difference observed in willingness to donate for Black men and women relative to 
Whites (Boulware et al., 2002). A qualitative study by Thompson (1993) revealed that many 
African Americans believe they need their organs for resurrection in order to bring their death to 
completion, although participants noted that religious beliefs did not have an impact on their 
decision to donate. Some African Americans continue to hold certain religious misconceptions 
about donation although all major religions such as Christians, Amish, Buddhism and Hinduism 
support and encourage organ donation (Gallagher, 1998). Some researchers advocate for the 
inclusion of the clergy and utilization of altruistic values in Christian beliefs to promote donation 
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(Ariola et al., 2005; Boulware et al., 2002). The impact of religious beliefs is substantial to 
Blacks’ ability to pursue transplantation and serves as another barrier to organ donation and the 
procurement of transplantable kidneys.  
            Socioeconomic factors such as income, education and insurance status affect 
transplantation accessibility. These factors impact the distribution of wealth, power and 
opportunities among people (see Churak, 2005; Joshi et al., 2012), making it difficult for some 
people to access the best services and treatment. Patients who are listed on the transplant waitlist 
tend to be well-educated, employed and have health insurance particularly private insurance 
(Churak 2005; Coorey, Paykin, Singleton & Gaston 2009; Joshi et al., 2012; Soucie, Neylan & 
McClean, 1992). Income alters treatments choices given that patients with more money can seek 
superior treatments including specialty services, and have better access to transportation 
(Axelrod et al., 2010; Held et al., 1988). People from low socioeconomic backgrounds, many of 
whom are Black, tend to be less educated and thus have less awareness of the benefits of renal 
transplantation (Naveneethn & Singh, 2006). Subsequently, these patients may exhibit poor 
medical compliance (Naveneethn & Singh, 2006), further reducing their likelihood of seeking 
transplantation. ERSD patients without insurance or with limited insurance show a reduced 
likelihood of maintaining doctors’ appointments since they may have concerns about costs and 
payments (Churak, 2005). Some research suggests that African Americans are in favor of 
financial reimbursement for deceased donor’s funeral expenses, cash payments to deceased 
donor’s families or estates, cash payments to deceased donor’s charity of choice, tax breaks for 
deceased donor’s families, and reimbursement of deceased medical expenses after adjustments, 
among other compensations. Nonetheless, these public incentives have been debated with 
strongly voiced objections to such compensations (Boulware, Troll, Wang & Powe, 2006). 
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             It is apparent that kidney transplantation for African Americans is influenced by a 
myriad of factors which may affect their beliefs about donation, their knowledge of 
transplantation and their ability to obtain transplantable organs. Nonetheless, should ESRD 
patients decide to seek a medical evaluation, it is necessary to understand the factors that may 
facilitate or impede their success.   
Factors that positively impact completion of the medical evaluation for kidney 
transplantation 
Weng and colleagues (2005) proposed that social networks could improve pre-transplant 
work up completion rates since patients with previous knowledge about transplantation 
facilitated by their family and/or friends, may be prone to perceive transplantation as a viable 
treatment option. In a study of both patient attendees and non-attendees of the initial visit for a 
medical evaluation, Dageforde and colleagues (2015) found a relationship between attendance 
and patient’s reported knowledge of transplantation. Churak (2005) advocated for increasing 
patient social networks among African Americans to become more heterogeneous since this 
could increase access to information about the benefits of kidney transplantation. Consequently, 
this could propel Black ESRD patients to complete the evaluation process.  
According to Clark, Hicks, Keogh, Epstein and Ayanian (2008), the medical evaluation 
can be difficult to finish when a patient has clinical and social problems. As their study revealed, 
increases in levels of instrumental support networks was connected to better completion rates 
among Black women, after examining Black and White ESRD patients who had started dialysis 
in four regional networks. The authors recommend the use of instrumental social support to 
assist with tasks such as cooking, cleaning, scheduling appointments, navigating health care 
systems, and child care in order to help patients pursue and complete diagnostic evaluations 
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(Clark et al., 2008). Supplemental private insurance was noted as a possible motivator for 
completing pre-transplant work ups among Black men (Clark et al., 2008). Garg and colleagues 
(2001) further advocated for an intervention which targets young Black men to reduce the 
disparity in transplant activation. This is because young Black men are less likely to be listed for 
a transplantable organ although they have a better chance of survival because they may have 
fewer health problems aside from renal disease (Garg, Diener-West & Powe, 2001).  
Support from physicians and healthcare professionals can be advantageous to Blacks 
completing the medical evaluation. Black patients were more likely to complete the medical 
evaluation when their physicians appeared to be invested in their care and expressed a preference 
for transplantation (Clark et al., 2008). Other recommendations for improving kidney 
transplantation access include minority education about renal disease, post–secondary education, 
media promotion, emotional support and counseling, more diverse clinicians, and ongoing 
encouragement during the transplant process (Churak, 2005; Moore, 2007).  
Navigators, health care providers who educate patients and guide them through the 
medical system, can also be helpful in assisting ESRD patients through the medical evaluation 
process (Sullivan et al., 2012). A study which implemented an intervention with navigators 
reported that patients completed the transplant steps faster than the control group without 
navigators (Sullivan et al., 2012). This shows the potential of faster pre-transplant work up 
completion when patients are educated and supported throughout the process. Additionally, 
social networking websites have been found to be useful for helping kidney patients provide 
information about transplantation and solicit living donors (Chang, Anderson, Turner, Shoham, 
Hou & Grams, 2013). The literature provides some suggestions and presents minimal study 
findings regarding the factors which facilitate the completion of the medical evaluation 
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suggesting that this is an area for more research. See Table 1 for a compiled list of proposed 
factors that positively impact patients’ completion of the medical evaluation for transplantation.  
Table 1 
Facilitators of Medical Evaluation Completion  
 
 Factor Study 
Accessible or free transportation Churak, 2005 
Diverse clinicians Churak, 2005 
Education of minority groups about renal disease Churak, 2005 
Emotional support and counseling Churak, 2005 
Knowledge about transplantation Dageforde et al., 2015 
Instrumental support with tasks such as cooking and 
cleaning 
Clark et al., 2008 
Interventions targeted towards Black men Garg et al., 2001 
Media promotion Moore, 2007 
Navigators Sullivan et al., 2012 
Physician investment Clark et al., 2008 
Private insurance Clark et al., 2008 
Post-secondary education Moore, 2007 
Social networks to facilitate knowledge about 
transplantation 
Churak, 2005; Weng et al., 2005 
Social networking websites Chang et al., 2013 
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Factors that negatively impact completion of the medical evaluation for kidney 
transplantation 
Patient-related elements like socioeconomic status (i.e.; unemployment, lack of health 
insurance, poverty), comorbid illnesses which in turn increase the number of tests a person has to 
undergo during the evaluation, and beliefs about transplantation delay the completion of the pre-
transplant workup (Danovitch et al., 2004; Navaneethn & Singh, 2006; Weng et al., 2005). A 
study by Weng and colleagues (2005) examined rates of completion of 175 patients who were 
undergoing the pre-transplant work up for a kidney transplantation. Findings indicated that 
Blacks were less likely to complete the medical evaluation; failure to complete the process was 
associated with more comorbidities, which likely slowed the process due to the additional 
medical tests needed to confirm candidacy. Synonymous findings were reported by Danovich 
and colleagues (2004) who found that patients with more complex illnesses had prolonged or 
incomplete workups. Patients who first heard about transplantation from their nurses or doctors 
reported a reduced likelihood in completion of their pre-transplant work up. Weng and 
colleagues (2005) attributed this to patients’ lack of close relations to educate them about 
transplantation (Weng et al., 2005). Thus, the lack of prior knowledge about the medical 
evaluation for transplantation serves as a barrier to completing the process.  
Another study examining 2,291 patients referred for medical evaluation (1,486 Blacks 
and 805 Whites) reported higher rates of incompletion of the requirements for evaluation among 
Blacks relative to Whites (45.7 vs 17.9) (Patzer et al. 2012). Blacks in this study were less likely 
to have health insurance and more likely to live in poor neighborhoods. Socioeconomic factors 
such as insurance, education, employment, distance, neighborhood poverty and degree of rurality 
accounted for some of the variability in completing several transplant steps such as starting 
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evaluation, completing evaluation and being waitlisted. Indeed, patients with higher 
socioeconomic status progressed faster through the transplant steps (Patzer et al. 2012). In 
contrast, patients with low SES often delay seeking medical care and specialty services which 
results in delayed referrals to regional transplant centers, evaluations, and enrollment on the 
waitlist (Axelrod et al., 2010). Patients who initiate the medical evaluation for kidney 
transplantation report concerns related to finding a living donor, and concerns about the cost of 
the medical evaluation, transplant operation, transportation and medications. Furthermore, those 
who are listed at other transplant centers may be less compelled to complete their evaluation due 
to transportation difficulties (Dageforde et al., 2015). These findings provide support for the 
impact of socioeconomic factors in the completion of the pre-transplant work up.  
Other patient-related factors also affect the completion of the medical evaluation. 
Distance from the transplant center is another factor that has been discussed in the literature and 
shown to delay the medical evaluation process. Blacks living in rural areas are inclined to 
experience transportation problems in their attempts to get to the transplant center, impeding 
placement on the waitlist (Danovich et al. 2004; O’Hare, Johansen & Rodriguez, 2006). Dialysis 
status could also reduce a patient’s ability to complete the pre-transplant work up since dialysis 
patients may be less motivated to seek transplantation. This could be attributed to a number of 
reasons such as feeling sick after using the dialysis machine and patient’s perception that he or 
she is functioning well on dialysis. Hospitalizations and the navigation of complications 
associated with dialysis therapy could also hinder progression through the medical evaluation 
(Weng et al., 2005). Furthermore, extended dialysis use makes it harder to have a successful 
transplant given that it increases the patient’s susceptibility to other illnesses and poor physical 
health, reducing the chances of receiving a transplantable kidney. Consequently, since the 
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majority of Black ESRD patients are on dialysis, this reduces their ability to finish the pre-
transplant work (Weng et al., 2005). Also, findings from Clark and colleagues (2008) show that 
renal patients who perceive the dialysis and patient support staff as important to their treatment 
are less likely to complete pre-transplant workup (Clark et al., 2008). It is possible that these 
patients wish to maintain the relationship they have with the dialysis staff and are thus reluctant 
to pursue transplantation since dialysis becomes a part of their socialization. Blacks are less 
likely to recognize potential benefits of transplantation, less likely to be referred, and are referred 
later than Whites, increasing the likelihood that they have already initiated dialysis therapy 
before considering transplantation as a treatment option (Alexander et al., 1998; Rodrigue, 
Cornell, Kaplan & Howard, 2008). Therefore, it is critically important that the patients who 
present at a transplant center for evaluation complete the pre-transplant work up to get listed.  
Healthcare-related barriers linked to medical evaluation completion revolve around racial 
discrimination and difficulties in the physician-patient relationship. Reports of racial 
discrimination by African American patients reduces their desire to seek transplantation given 
that they have to go to unfamiliar healthcare settings (Klassen, Hall, Saksvig, Curbow & 
Klassen, 2002). Victims of discrimination anticipate poorer outcomes and expect to be treated 
poorly which makes them reluctant to access new treatment settings. According to Klassen et al., 
(2002), most African Americans report more positive racial relationships in dialysis centers 
which reduces their desire to seek new treatment facilities.  
The role of the physician is very important in motivating patients to pursue 
transplantation. Doctors are less likely to provide Blacks with information about transplantation 
relative to White patients (Kasiske, London & Ellison, 1998; Joshi et al., 2012). Healthcare 
professionals may consciously or unconsciously discriminate against disadvantaged people, 
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many of whom are African American and turn out to be medically non-adherent, resulting in 
barriers to placement on the waitlist (Kasiske, London & Ellison, 1998). Blacks are prone to 
remain on the waitlist for long periods of time and have a reduced likelihood of receiving an 
organ in comparison to Whites (Callender & Miles, 2004). Hence, Black patients with an 
awareness of their reduced chances of obtaining a kidney transplant could be deterred from 
completing the medical evaluation.   
Lower referral rates impact the initiation of the pre-transplant work up, creating problems 
for African Americans seeking renal transplantation (Alexander & Sehgal, 1999; Joshi et al., 
2012). This could be attributed to factors such as less interest in transplantation and physicians’ 
beliefs about transplantation (Alexander & Sehgal, 1999; Ayanian et al., 2004). Doctors may be 
less likely to view transplantation as a superior treatment for Black ESRD patients in comparison 
to Whites, although they perceive transplantation to improve the quality of life for ESRD 
patients over dialysis therapy (Ayanian et al., 2004). In cases where nephrologists practiced in 
two or more dialysis facilities, Blacks reported receiving less information or no information 
about transplantation than Whites (Ayanian et al., 2004). Reports indicate that Blacks have better 
outcomes on dialysis, which could lead to the misconception that kidney transplantation may not 
be appropriate or not needed for them (Churak, 2005). Health literacy, a concept used to the 
explain a patient’s capacity to navigate the health care system either by understanding medical 
terminology or services in order to make informed decisions about one’s health, has been linked 
to the accessibility of kidney transplantation (Grubbs, Gregorich, Perez-Stable & Hsu, 2009). 
Low health literacy has been shown to produce poorer health outcomes and health care 
consumption. A study by Grubbs and colleagues (2009) indicated that inadequate health literacy 
was associated with lower rates of referrals among 45 Black patients and 17 White patients 
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receiving hemodialysis (Grubbs et al., 2009). Taken together, past research indicates several 
barriers in accessing transplantation among African Americans. Refer to Table 2 for a compiled 
list of factors that negatively impact the completion of the medical evaluation.  
Table 2 
Impediments to Medical Evaluation Completion  
 
Factor Study 
Being listed at different transplant centers Dageforde et al., 2015 
Comorbidity which results in additional testing Danovich et al., 2004; Weng et al., 2005 
 
Concerns about finding a living donor  Dageforde et al., 2015 
Dialysis status Weng et al., 2005 
Dialysis center as main form of social support   Clark et al., 2008 
Distance from the transplant center Danovich et al., 2004; O’Hare et al., 2006 
First knowledge of transplantation from nurses or 
doctors 
Weng et al., 2005 
Lack of health insurance Patzer et al., 2012 
Late referrals or fewer referrals from doctors Alexander & Sehgal, 1999; Joshi et al., 2012; 
Rodrigue et al., 2008  
Less knowledge about the potential benefits of 
transplantation  
Alexander & Sehgal, 1999 
Limited health literacy  Grubbs et al., 2009 
Low SES Axelrod et al., 2010; Navaneethn & Singh, 2006; 
Patzer et al. 2012 
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Physician beliefs about transplantation Ayanian et al., 2004 
Reports of racial discrimination Kassike et al., 1998; Klassen et al., 2002 
 
Theoretical Framework  
 The Health Beliefs Model was used as a guide in understanding factors that impact 
kidney patients’ completion of the medical evaluation process. Developed in the 1950s, the 
Health Beliefs Model was used to explain the utilization of health services. The model proposes 
that an individual would be more likely to use health promotion strategies to avoid or manage a 
disease based on the person’s perception of their susceptibility and the severity of the disease. 
Additionally, the individual is more likely to engage in efforts to avoid or reduce the severity of 
the disease assuming these strategies are useful and not accompanied with barriers such as costs, 
convenience and pain (Rosenstock, 1974). Variations in perceived susceptibility of a disease or 
illness may range from complete denial to perceiving the illness as a serious threat to the 
individual’s physical health. An individual’s perception of the severity of an illness may be 
determined by both psychological and physical consequences of the illness. For example, 
concerns that the illness may be deadly and/or cause psychological impairment or negatively 
impact the individual’s social functioning. Accepting one’s susceptibility to an illness may 
promote taking action to prevent or manage the disease which is in turn influenced by the 
individual’s perception of the costs and benefits associated with taking that action. Hence, the 
individual is more likely to engage in preventive health behaviors or treatment when 
susceptibility or the severity of the illness can be reduced. Psychosocial and economic factors 
such as the impact on the family unit, personal motivation, level of psychological distress, and 
expenses also play a role in whether the individual chooses to engage in the health behavior. 
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Internal or external cues to action (e.g., personal realization of the individual’s health status, 
education about the illness, family encouragement to engage in health behavior) may further 
propel the person to engage in the health behavior (Rosenstock, 1974). Specific to kidney 
transplantation, patients’ decision to complete the medical evaluation may be influenced by 
perceptions of susceptibility to more adverse outcomes such as death, either from stay on 
prolonged dialysis or from the surgical procedure for transplantation, and the severity of their 
illness (e.g., some patients’ health may have significantly deteriorated due to prolonged dialysis 
use or due to other comorbidities). Additionally, patients may base their decision to complete the 
evaluation process on the costs and benefits of transplantation. For example, patients who rely on 
dialysis centers as their main source of support may be less inclined to complete the medical 
evaluation process; whereas those who see the adverse effects of prolonged dialysis use may be 
more inclined to finish the process. Further, cues to action such as education about the benefits of 
kidney transplantation may encourage some patients to complete their evaluation. Figure 1 
provides a representation of how this model may be used to understand factors that impact 
completion of the medical evaluation. 
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Figure 1. Hypothetical demonstration of the Health Beliefs Model to understand factors that are 
likely to impact completion of the medical evaluation for kidney transplantation. 
Statement of Problem 
As revealed in the discussion above, past research highlights a variety of factors that 
impact African American ESRD patients’ ability to access kidney transplantation. However, 
there is no clear consensus as to which factors facilitate and hinder the pre-transplant work up in 
order to have patients registered on the transplant waitlist. Thus, further investigation is 
Perceived susceptibility 
to adverse health 
outcomes (e.g., 
prolonged dialysis use 
resulting in poor health) 
Demographic variables (e.g., 
gender, age) 
Psychosocial variables (e.g., 
denial of disease, lack of 
familiarity with renal disease in 
social network) 
Structural variables  
(e.g. knowledge of ESRD or the 
benefits of transplantation) 
Perceived threat of renal failure 
(or prolonged dialysis use)  
Cues to action  
(e.g., accessible or free 
transportation, comprehensive 
insurance, education about  
the benefits of transplantation, 
navigators) 
Perceived benefits  
(e.g., desire to get off dialysis, 
better quality of life) 
minus 
Perceived barriers 
(e.g., insurance issues, low SES) 
Likelihood of completion 
the medical evaluation 
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warranted regarding the pre-transplant work up process in order to help reduce disparities in 
access to transplantation.  
This study explored the views of transplant professionals and ESRD patients regarding 
barriers and facilitators to completion of the medical evaluation for kidney transplantation. The 
purpose of this study was to determine specific factors that predict completion of the medical 
evaluation by identifying the most significant barriers and motivators. The findings may provide 
insight that could lead to systemic changes to improve rates of completion of the medical 
evaluation process for African Americans. Subsequently, understanding barriers and motivators 
to completing the medical evaluation will serve to fulfil the needs of patients, in order to reduce 
health disparities between African Americans and other racial groups. Recent studies have 
accessed physician beliefs about transplantation accessibility but no study to date has assessed 
transplant professionals’ views of the factors that impact the completion of the medical 
evaluation. This study sought to extend the literature by providing a comprehensive view on the 
medical evaluation process by examining African American ESRD patients and different 
transplant professionals such as nephrologists, transplant coordinators and social workers, all of 
whom are integral to the completion of the pre-transplant work up. This will provide a thorough 
understanding of the facilitators and barriers to initiating and completing the pre-transplant work 
up. The use of a mixed methods approach serves to shed light on this phenomenon as the 
qualitative and quantitative approaches complement each other, and provide a detailed portrait of 
the most important factors impacting completion of the medical evaluation for Black ESRD 
patients.  
 
 
 27 
 
Study Aims 
The present study sought to identify the factors that impact the completion of the medical 
evaluation process for kidney transplantation among African American ESRD patients. It is 
guided by the following overarching questions:  
1. What factors facilitate and impede the initiation and completion of the medical evaluation 
process for kidney transplantation? 
2. What are the most significant factors to initiating and completing the medical evaluation 
process?  
Aim 1: To identify barriers and motivators to completing the evaluation process as perceived by 
transplant professionals.  
Research Question (RQ) 1: What are the barriers to renal patients’ completion of transplant 
evaluations as perceived by transplant professionals (e.g., nephrologists, coordinators, social 
workers)? 
RQ 2: What factors motivate patients to complete the transplant evaluation process as perceived 
by transplant professionals (e.g., nephrologists, coordinators, social workers)? 
RQ3: Are there differences in perceptions of the motivators and barriers by transplant 
professionals (e.g. differences between nephrologists, coordinators and social workers)? 
Aim 2: To identify the most significant barriers and motivators to completing the transplant 
evaluation process as perceived by ESRD patients by incorporating the list of barriers and 
motivators solicited by the transplant professionals 
RQ 4: What barriers do patients cite as impediments to completing the evaluation for 
transplantation? 
RQ 5: What factors facilitate patients’ completion of transplantation evaluations? 
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RQ 6: How do patients rank the barriers to completing the medical evaluation for 
transplantation? 
RQ 7: How do patients rank the motivators to completing the medical evaluation for 
transplantation? 
Aim 3: To identify differences in perceptions of the factors that impact the completion of the 
medical evaluation process as determined by patients and transplant professionals.  
RQ 8: How do rankings differ between patients who have completed the process (Status 1 and/or 
2) and patients who have not (Status 7)? 
RQ 9: How do rankings differ between patients and transplant professionals? 
Method 
This study applied a mixed-methods design to examine factors associated with 
completion of the medical evaluation process for kidney transplantation. The two phases of the 
proposed study utilize both qualitative and quantitative data collection methods through the use 
of focus groups with a nominal group technique (NGT) and semi-structured interviews, as well 
as survey data with participant ratings.  All phases of the study were approved by the 
Institutional Review Board (IRB) at Virginia Commonwealth University (# HM20001313). 
Phase I 
Participants  
 The first phase of the study consisted of semi-structured interviews with a stratified 
purposeful sample of transplant professionals (N =23). Purposeful sampling aims to gather 
information rich cases for a thorough examination of a phenomenon (Patton, 1990). Specifically, 
stratified purposeful sampling helps illustrate the characteristics of particular subgroups and 
creates an avenue for making group comparisons (Patton, 1990). Participants consisted of 
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nephrologists (n = 6), transplant coordinators (n = 8), social workers (n = 6), psychologists (n = 
2), and a transplant nurse practitioner (n =1). The majority of transplant professionals were 
female (n=16; 69.6%) self-identifying as Asian (8.7%), Black/African American (13.0%), and 
the majority as White (78.3%). On average, these professionals had 10.24 (SD = 8.65) years’ 
experience working with transplant patients undergoing the medical evaluation process. The 
majority of these professionals had a medical degree (34.8%) or master’s degree (34.8%), and 
the rest had some graduate training (4.3%) or a bachelor’s degree (26.1%).  
Procedure  
Participants were recruited from nine transplant centers in the Mid-Atlantic, Mid-Western 
and Southeastern regions of the United States. They were invited to participate in the study via 
phone or email correspondence, listservs, letters and through word of mouth or snowballing 
techniques (e.g., other transplant professionals informing potential participants about the study). 
Data collection took place over a five-month period from September 2014 to January 2015. 
Semi-structured interviews were used for data collection. The interviews were digitally audio-
recorded and lasted approximately 60 minutes; all interviews were conducted by the principal 
investigator, a middle-age Black woman in a private room. At the beginning of each interview, 
participants were provided with information about the structure of the interview and verbal 
informed consent was obtained from all participants before recording the interview. Nine 
interviews were conducted in person and 14 were held via telephone to maximize enrollment in 
the study. Additionally, participants were asked to complete a survey capturing demographic 
information and questions assessing participants’ ratings of factors that impact the medical 
evaluation process. Participants were compensated with a $5 Starbucks gift card as gratitude for 
participating in the study.  
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Semi-structured Interviews 
Semi-structured interviews allow for the collection of comprehensive information about 
participants’ perceptions of the factors associated with completion of the medical evaluation 
process. This form of data collection facilitates the expression of thoughts, feelings and attitudes 
in a private setting. Semi-structured interviews usually consist of observations of behavioral 
patterns, casual and unstructured interviewing. Open-ended questions provide some structure and 
also allow for gathering different ways of perceiving the topic discussed (Cohen & Crabtree, 
2006).  Some of the questions included in interview are: 1) How long does it take the average 
patient to complete the evaluation process? 2) What individual-level factors impede patients’ 
completion of the evaluation process? 3) What would you recommend to help African American 
patients, specifically, complete the medical evaluation process and reduce disparities in this 
aspect of transplantation? (Refer to Appendix A for a complete description of the questions). The 
semi-structured interview was initially pilot tested by the principal investigator and her 
supervisor (HMT) prior to recruitment. The structure of the protocol and some of the initial 
questions were edited after the pilot test and feedback received from the first four participants. 
The addition of several open-ended questions and probes helped ensure a thorough examination 
of the issue. The information gathered on barriers and motivators to completing the medical 
evaluation process was incorporated into the second phase of the study. 
Quantitative Measures  
In addition to the interviews, participants were asked to complete a brief quantitative 
survey (paper or online version via SurveyMonkey.com). The survey was designed to elicit 
ratings of the potential barriers and motivators to patients’ completion of the medical evaluation 
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process as identified in the extant literature. A copy of the survey is provided in Appendix B and 
the specific measures included are described below. 
Perceived barriers. Ten 7-point Likert-type questions were used to assess perceived 
barriers to completing the medical evaluation process. Specifically, respondents were asked to 
indicate the extent to which each potential barrier impacted patients’ completion of the medical 
evaluation along a 7-point scale (1-Not at all /7-Strongly impacts). These questions were 
developed for this study and informed by the past literature on proposed barriers to completing 
the medical evaluation process. Individual items were summed to create a global measure of 
perceived barriers (Cronbach’s alpha (α) = 0.84).  
Perceived motivators. Two 7-point Likert-type questions, informed by the past literature 
on proposed motivators to completing the medical evaluation process were used to assess 
transplant professionals’ perceptions of their impact on the medical evaluation process (1-Not at 
all/7-Extremely positive impact). The first question measured navigators as a motivator for 
completing the medical evaluation process (i.e. how much would navigators impact an African 
American patient’s ability to complete the medical evaluation process?) and the second question 
measured instrumental support (i.e. how much would instrumental support impact an African 
American patient’s ability to complete the medical evaluation process?).   
Demographic information. Demographic information was also collected (e.g., years of 
education, racial/ethnic background and type of occupation).  
Phase II 
Participants 
 The second phase of the study consisted of purposeful sample of African American renal 
patients (N = 30).  Patients who have completed the medical evaluation process are assigned a 
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status of 1 or 2. Status 1 patients have been cleared for a transplant, and could receive a call for a 
transplantable kidney at any time. Status 2 patients have also been cleared but their need for an 
organ may not be as urgent as a Status 1 patient. Status 7 patients are those who have not 
completed the pre-transplant work up or those who have been added to the transplant list but are 
not yet cleared due to medical, financial or psychosocial reasons (Pham, Pham, Pham, Pham & 
Pam, 2011). To secure a full understanding of the motivators and barriers, ESRD patients with a 
Status 1 assignment (n = 10) and Status 7 patients (n = 20) who had not completed the pre-
transplant workup at the time of enrollment were recruited. The study sought to recruit equal 
numbers of patients who had completed the medical evaluation and those who had not. However, 
recruitment yielded more Status 7 patients, which is preferred given that one of the main goals of 
the study is to identify barriers to completing the medical evaluation process.  
 Participants consisted of Black/African Americans (100%) with 21 (70%) men and 9 
women (30%) and a mean age of 49.79 (SD = 8.57). The majority of patients were single 
(33.3%) or married/cohabited (33.3%) and the remaining were divorced (23.3%), separated 
(3.3%) or widowed (6.7%). Participants’ identified their religious affiliation as Protestant (60%), 
Catholic (13.3%), Other (13.3%, including people who identified as non-denominational and 
Jehovah’s witness), and four patients did not report a religious affiliation (13.3%). Twelve 
patients (40%) had a high school education or less and another twelve patients (40%) had an 
Associate’s degree or some college. Six patients had a Bachelor’s degree (10%) or some 
graduate training/Master’s degree (10%). Most of the patients (53.3%) had an annual household 
income of less than $20, 000, eight patients had an annual household income of less than 
$40,000, two reported that their household income was less than $60,000 and the rest (10%) had 
an income of $60,000 or more. One person did not report their income.  
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Procedure 
Participants were recruited from one Mid-Atlantic transplant center in the United States 
from which the principal investigator obtained a list of African American patients who had either 
completed the medical evaluation or were in the process of doing so. Potential participants were 
mailed a letter inviting participation in the study. They were then contacted via telephone to 
solicit questions and invite participation; patients expressing interest were scheduled to attend 
one 90-minute focus group interview. Data collection took place over a ten-month period from 
March 2015 to December 2015. Refer to Figure 1 for a complete description of the data 
collection methods by study phase.  
Due to the high no-show rate, both in-person semi-structured interviews (n =8) and focus 
groups (n = 22) were used for data collection. For example, five patients would be scheduled for 
a focus group and one patient would show up. Consequently, semi-structured interviews were 
conducted in place of a focus group when there was only one patient present. The focus group 
moderator’s guide was initially pilot tested by the principal investigator and research assistants 
prior to recruitment. The focus groups (or semi-structured interviews) were conducted in a 
private room conference (with a whiteboard) located in an office building of a local university. 
The focus groups were digitally audio-recorded and lasted between one to two hours (semi-
structured interviews last about thirty); all interviews were moderated by the principal 
investigator (PI), a middle-age Black woman and co-moderated by a research assistant, who 
made observations and took notes. The racial/ ethnic backgrounds of the co-moderators (research 
assistants) included Asian (n =1), Black/African American (n =3), Hispanic (n =1) and White (n 
=2). At the beginning of each focus group interview, participants were provided with focus group 
guidelines (e.g. confidentiality and use of first names only or pseudonyms; Appendices C & D). 
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A total of nine focus groups were conducted that ranged in size from two to four participants; 
three (n =2), two (n =3), one (n =4) Status 7, and three (n =2) Status 1.  
The last two questions of the focus group applied a nominal group technique which 
required participants to rate the most significant barriers and motivators to completing the 
medical evaluation individually and together as a group. Patients were given the option to 
incorporate information gathered from transplant professionals from phase I (i.e. a list of barriers 
and motivators) before finalizing their group rankings. At the end of each focus group or semi-
structured interview, participants were asked to complete a paper survey which included 
demographic information and questions assessing participants’ ratings of factors that impact the 
medical evaluation process (See Appendix E). Light refreshments were provided during each 
session, and participants were compensated with a $20 visa gift card as gratitude for their 
participation. 
Phase One 
(Transplant professionals) 
Phase Two  
(ESRD patients) 
 
Semi-structured 
interviews 
(N = 23) 
 
 
Focus groups with ESRD patients 
(N = 30) 
 
 
Nephrologists, Coordinators, Social workers 
  (n = 6)    (n = 8)             (n = 6) 
 
Psychologists,  Transplant Nurse Practitioner 
 (n = 2)             (n = 1)              
 
Status 1 / 2  
(n = 10)  
Status 7 
(n = 20) 
 
Figure 2. Data Collection by Phase  
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Focus group with Nominal group technique (NGT) 
Focus groups are a data collection technique that facilitate group interaction (Ashbury, 
1995). A highly structured focus group with a nominal group technique (NGT) was used to 
gather information about the phenomenon under investigation (Morton, Tong, Webster, Snelling 
& Howard, 2011). Focus groups with an application of a nominal group technique (NGT) 
employ a group process in which members work independently within the presence of others to 
yield quantitative data that are then explained by the qualitative component (Delp, Thesen, 
Motiwalla & Seshardi, 1977). Subsequently, group members interact with each other to discuss 
ideas generated throughout the process. Finally, participants weigh the ideas generated against 
others, and rank-order the items on a scale of importance (Delp et al., 1977). NGTs allow for the 
solicitation of views from interviewees, and provide a means of gathering information from each 
group member on predetermined questions. Additionally, it provides two forms of output; a list 
of items relevant to the topic (for this study the output will be factors that are associated with the 
completion of the medical evaluation), and quantified individual and collective measures of the 
items identified (Delamere, Wankel & Hinch, 2001). The qualitative data generated provides a 
rationale for why participants rank certain items as being most and least important (Corner et al., 
2007). Developed by Van de Vaen and Delbecq (1972), NGTs prevent interviewees from 
tailoring their answers to the interviewer’s nonverbal responses (Porter, 2013). This technique 
facilitates the prioritization of ideas (Harvey & Holmes, 2012) which in this study would be 
ranking the factors with the greatest impact on patients’ completion of the medical evaluation 
process.  
In a typical focus group with NGT, the moderator poses a question to the group and each 
member writes down as many ideas as possible. The moderator asks each group to share the 
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ideas generated, which is written on a flip chart for all group members to see. Discussions do not 
occur until each member has shared their ideas. The ideas generated are then discussed together 
and as a group. Finally, group members prioritize the most important items or ideas. The 
outcome is a mathematical cumulative of individual member preferences to provide group 
rankings (Delp et al., 1977). Modified from the NGT used by Corner and colleagues (2007), the 
focus group interviews conducted in the current study began with introductory questions and 
transition questions, before key questions were asked using the nominal group technique (Corner 
et al., 2007).   
NGTs have been applied in health research and have been used to identify areas of 
priority in research (Corner et al., 2007). This technique has been used in several studies by the 
National Institutes of Health (NIH) since 1977 to gather information on different health related 
topics (Fink, Kosecoff, Chassin & Brook, 1984). NGTs have also been applied to research in 
educational settings, social service and government organizations (Fink et al., 1984).  Morton 
and colleagues (2011) used the NGT as a mixed methods approach to gather characteristics of 
dialysis important to patients and family caregivers (Morton et al., 2011).  
For example, Status 1 patients were asked: 1) What are some things that made it easier to 
complete the medical evaluation process for kidney transplantation? 2) What are some things 
which made it difficult to complete the medical evaluation process? Questions posed to Status 7 
were modified as appropriate and included: 1) What are some things which have made it difficult 
to complete the medical evaluation process? 2) What do you think will help you complete the 
medical evaluation process for kidney transplantation? Open-ended questions and the use of 
probes were used to prompt participants to elaborate on or provide more detail about their 
responses. The full moderator’s guides are provided in Appendices C & D. 
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Quantitative Measures  
The same questionnaire administered to the transplant professionals in phase I was 
administered to patients in Phase II. The patient version of the demographic questions had 
additional patient-specific questions such as health insurance status and distance from the 
patient’s house to the transplant center (see Appendix E). 
Data Analysis 
Qualitative analysis  
Information from the semi-structured interviews and focus groups were audio-recorded, 
de-identified, and transcribed verbatim by a research assistant. The transcripts were then 
reviewed by another research assistant and edited as needed, to ensure that the information had 
been accurately transcribed. Consequently, the transcripts were uploaded into MAXQDA 11, a 
qualitative and mixed-methods software for data analysis. 
Grounded theory. Grounded theory was used as a theoretical paradigm for assessing the 
qualitative data gathered in Phases I and II. This theory is particularly advantageous for 
analyzing qualitative data since it has the potential to lead to the development of a theory 
(Creswell, 2007) , which would to explain relationships between and among factors that facilitate 
or impede the completion of the pre-transplant work up. According to Strauss and Corbin (1998), 
grounded theory brings awareness to and offers a meaningful guide to action which enhances 
understanding of a phenomenon (Strauss & Corbin, 1998). This theory uses constant 
comparative analysis where the data is coded into categories and then recoded to develop 
themes, leading to the development a theory (Birks & Mills, 2011; Glaser & Strass, 2012). 
Rigorous coding procedures such as open coding, axial coding and selective coding guide the 
analyses to derive meaning from the data (Strauss & Corbin, 1998).  
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Open coding utilizes an analytic process to generate concepts in relation to their 
properties and dimensions. During open coding, data is broken down into discrete parts, closely 
examined, and compared for similarities and differences (Strauss & Corbin, 1998). Events, 
happenings and/or actions which are conceptually synonymous are grouped under more abstract 
concepts called categories (Strauss & Corbin, 1998). Specifically, this study reviewed the 
responses from each discussion topic generated from the semi-structured and focus group 
interviews to assign code names. These codes were then used to produce major categories and 
subcategories. A preliminary coding scheme was developed by the PI through open coding in 
MAXQDA 11. Consequently, a coding manual was developed with clear definitions for each 
code. New codes were included under an Other category for further examination, discussion and 
categorization. Three research assistants also coded the data to facilitate inter-coder reliability 
(i.e. transcriptions were divided among research assistants for coding whereas the PI coded all 
transcriptions). All team members created their own projects in MAXQDA.  
Axial coding was used as the next step in the coding process, wherein categories are 
related to their subcategories along the lines of their properties and dimensions. This process 
aims to determine how categories crosscut and link (Strauss & Corbin, 1998). During this stage 
of the coding process, the data is assessed in new ways and responses generated are compared to 
each other. Finally, selective coding was performed to integrate the categories and refine them 
(Strauss & Corbin, 1998). This whole process involved a constant comparative analysis, as 
transcribed responses were compared to each other and themes emerged from the data. 
Information gathered from the interviewer/moderator notes during the semi-structured interviews 
and focus groups were also incorporated into the analyses. Data saturation was achieved when no 
new themes emerged from participants’ responses. 
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Trustworthiness. Trustworthiness is a way to increase rigor in qualitative studies and to 
assess the value of findings (Krefting, 1991). Specific strategies must be implemented to avoid 
possible threats and to test the validity (credibility) and reliability (dependability) of findings 
(Krefting, 1991; Maxwell, 2013). Verbatim transcripts of the semi-structured interviews and 
focus groups facilitated the collection of rich, detailed data, and provide a complete portrait of 
the phenomenon under investigation (Maxwell, 2013). Credibility and dependability was 
demonstrated through triangulation, which involves the use of a diverse sample and different 
data collection methods (Krefting, 1991; Maxwell, 2013). To facilitate triangulation, this study 
utilized semi-structured interviews and focus group interviews and recruited different transplant 
professionals, as well as patients at different points in the pre-transplant work-up. Further, the 
interviewer/moderator notes were also incorporated into the data analysis. Reflexivity, which is 
an assessment of the influence of a researcher’s background and perceptions of the research 
process (Krefting, 1991), is another strategy used to demonstrate credibility and was 
implemented in the current study. The PI kept a log to reflect on her experiences and 
methodological issues that arose during the research process. The PI and RAs also processed 
their experience of the focus group interviews and discussed group dynamics. As indicated by 
Maxwell (2013), these memos helped the PI develop a more thorough understanding of the topic, 
study and setting. Furthermore, dependability was established through peer examination where 
the PI discussed the findings with impartial colleagues specifically, other graduate students and 
faculty with expertise in qualitative research design. These colleagues checked the categories as 
developed and assessed disconfirming cases (Krefting, 1991). 
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Quantitative Analysis  
The quantitative data gathered from the surveys were entered into the statistical program, 
SPSS Version 23 (IBM Corporation, 2015), by the PI. Descriptive statistics such as means and 
standard deviations were calculated to characterize the transplant professional and patient 
samples. Given the small sample size of the study, and that the data did not meet the stringent 
assumptions of its parametric equivalent (Pallant, 2010; Rovai, Baker & Ponton, 2013), the 
Students t-test for independent samples (Levene’s test p >.05), the Mann-Whitney U was the 
preferred analytic approach for examining differences in perceived barriers and motivators to 
completing the medical evaluation process.  
Priority scores were calculated from the top five barriers and motivators (first = 5 points, 
second = 4 points, third = 3 points etc.) to completing the medical evaluation generated through 
NGT and summed across all focus groups and semi-structured interviews. The data was then 
presented as a percentage of the maximum possible priority score (number of participants 
completing rankings multiplied by 5 points) (Sanderson, Morris, Calnan, Richards, Hewlett, 
2010; Morton et al., 2011). The data for the group consensus of the top barriers and motivators 
was displayed  as a percentage of the weighted total score (Locke et al., 2015). 
Power Calculation. The G*Power statistical software (Faul, Erdfelder, Lang, & 
Buchner, 2007) was used to develop a priori power analyses to determine the most appropriate 
sample size for analyzing associations between perceived barriers and motivators. Power 
analysis for correlations using α = .05 criterion for achieving an 80% chance of detecting a large-
sized effect yielded the most conservative sample size estimate (N = 13). The total number of 
participants (N = 53) recruited for the study was above sample estimates for conducting the chi-
square tests and correlations. Given that the total sample size was small, A Mann U Whitney test 
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was used to examine differences in perceived barriers and motivators between transplant 
professionals in place of the parametric equivalent, an independent groups t test.   
Results  
Descriptive Statistics  
 Means, standard deviations, and counts were calculated for transplant professional and 
patient characteristics (see Table 3). Certain demographic data was not gathered given that not 
all questions were applicable to both subpopulations. 
 
Table 3 
Sample characteristics 
 
Variable Name  Total  Transplant Professionals   Patients  
   (N=53)   (n=23)     (n=30)  
Age      *    49.79 (SD =8.57) 
Gender 
   Male      7 (30.4)   21(70) 
Race  
  Asian      2 (8.7)    * 
  African American    3 (13)    30 (100) 
  White     18(78.3)   * 
Occupation 
  Nephrologists    6 (26.1)   * 
  Transplant Coordinators    8 (34.8)   * 
  Social Workers    6 (26.1)   * 
  Psychologists     2 (8.7)    * 
  Transplant Nurse Practitioner   1 (4.3)    * 
Education 
  High or less     *    12(40) 
  Associate’s degree/Some college   *    12(40) 
  Bachelor’s degree    6 (26.1)   3 (10) 
  Some graduate/Master’s degree  9 (39.1)   3 (10) 
  Doctorate/Medical degree      8 (34.8)   * 
Years of Experience     10.24 (SD =8.65)  * 
Marital Status  
  Single/Never married   *    10(33.3)   
  Married/Cohabit     *    10(33.3)   
  Divorced      *    7 (23.3)   
  Separated      *    1 (3.3)    
  Widowed     *    2 (6.7)     
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Religious Affiliation 
  Protestant     *    18(60) 
  Catholic     *    4 (13.3) 
  Other      *    4 (13.3) 
  Not reported     *    4 (13.3) 
Annual Household Income 
  $0 - $19,000     *    16(53.3) 
  $20,000-39,999    *    8 (26.7) 
  $40,000-59,999    *    2 (6.7) 
  $60,000+     *    3 (10) 
  Not reported     *    1 (3.3)   
Patient Perception of Completion1  
  Yes      *    18 (60) 
  No      *    12 (40)  
Patient Health Insurance Status   
  Yes      *    29(96.7) 
  No      *    1 (3.3) 
Distance to transplant Center (miles) *    12.54 (SD =8.15) 
Transportation  
  Yes      *    29(96.7) 
  Car Share     *     1 (3.3) 
Note. 1Patient perception of completion indicates patient’s perception of whether they have 
completed the medical evaluation or not. Values are expressed as count (percentage) unless 
noted otherwise. 
 
Thematic Analyses 
Transplant Professionals’ Identified Barriers to Completion of the Medical Evaluation  
 Thematic analyses were conducted to address RQ1, namely, identifying transplant 
professionals’ perceptions of barriers to patients completing the medical evaluation. These 
themes are presented here, in descending order, beginning with most frequently reported barriers.  
Theme 1: Individual-level barriers. Transplant professionals most often reported 
barriers that impact the patient at the individual level. The majority of these barriers consisted of 
socioeconomic impediments such as limited income, insurance issues and limited social support, 
personality characteristics such as personal motivation and fears, and belief systems such as 
medical mistrust or religious beliefs.  
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Subtheme (a): Socioeconomic barriers. Patients with limited income have a difficult time 
covering the costs associated with medication (e.g., immunosuppressants and steroids) and 
transportation. Insurance issues such as difficulty covering the necessary co-pays and frustrations 
with navigating insurance paperwork fall into this category. Additionally, those with limited 
social support experience barriers in completing the medical evaluation, resulting from lack of 
emotional support as well as difficulties with transportation and childcare. Examples of 
socioeconomic barriers are reflected in the following quotes from participating transplant 
professionals: 
Transplant Nephrologist: “Uh, biggest one is poorness. I mean that's it. I mean that's... 
Whether you're white or black, it doesn't really matter. But if you’re poor, you’re not 
going to, you have a less likelihood of having support, and having, you know, 
transportation, having all that stuff that you need to have to, uh, to complete the 
evaluation.”   
 
Transplant Coordinator: “Um, lower socioeconomic patients who don’t have the 
Medicaid full, the full Medicaid for transportation, and medications. Um, they’re going to take a 
while to get things done. Just because they don’t have the resources they need.”  
 
Transplant Coordinator: “Um, transportation can sometimes be a problem because a lot 
of the people who are on dialysis do not drive and they are reliant on other people to drive them 
so those people have to take time off work to do that.”  
Subtheme (b): Beliefs systems. Patients who do not believe that healthcare professionals 
have their best interest in mind or those with concerns about discrimination are less likely to 
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complete the pre-transplant workup. This is exacerbated by the fact that patients are asked to 
provide a thorough medical, psychosocial and financial history, consequently increasing their 
interactions with healthcare professionals. Transplant professionals noted that some patients with 
religious beliefs perceive the outcome of their illness to be in “God’s hands” or are cautious 
about seeking living donation. The following quotes reflect this subtheme:  
Social Worker: “Um, I think sometimes male patients in particular, um, and certainly 
middle-aged African-American men often, um, I think are a little bit tougher to, um, 
connect with, or in the sense that, in the way that I work with them as a social worker, I 
think sometimes they’re a bit distrusting with me and the questions that I have to ask and 
the things we have to go over.”  
 
Transplant Coordinator: “I think that sometimes people that are African American or 
even Hispanic if they’re hearing the message that we can’t move forward with transplant 
or there’s a barrier, occasionally, not very often, we will be told by that recipient, “well 
you don’t want to do this because I’m Black or because I’m Mexican.”  
 
Psychologist: “Actually, the times that that has come up it has been in African American 
patients. The times that either has been a belief that they will get healed; that they don’t 
need a transplant because a miracle will happen and they will get healed; um, or that 
they’ve stopped taking their medicine because they believed that God was going, that you 
know, God would protect them and they didn’t need to take their medication ‘cause God 
would heal them and make that kidney work. Um, those, those specific cases, and it’s 
only been a handful, have been in African American patients.”  
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Subtheme (c): Other individual-level barriers. Professionals also viewed patients who are 
unmotivated or passive as being less likely to complete the pre-transplant workup. According to 
the professionals interviewed, patients may be overwhelmed by the process, have fears about 
losing their benefits or making several hospital visits, and/or be afraid of the surgical procedure 
for transplant. Other patients may be less prepared for their appointments and may not have the 
appropriate paperwork. For example, a nephrologist reported, “…. Some people are just afraid of 
coming to a major hospital and navigating the corridors the hallways, uh, it’s the feeling of the 
unknown that they have to go through a surgery, uh, which might be a problem if they think, 
‘Okay, I’m on dialysis why do I need this big surgery….’” 
Theme 2: Informational/educational barriers: Barriers related to a patient’s lack of 
knowledge of the medical evaluation process, transplantation, and/or kidney disease were also 
cited by transplant professionals. Additionally, gaps in information provided to patients or gaps 
in patients’ formal education may impede comprehension of said information. These 
informational/educational barriers were the second most commonly identified type of barrier to 
completing the medical evaluation.  
Subtheme (a): Limitations in formal education. Several professionals reported that 
patients with limited formal education display challenges with literacy or comprehension of 
reading materials. For example, a transplant coordinator stated, “…If they’re not able to read all 
the information that we give them in the booklets or they don’t look it up on their own, I think 
that does play a factor into whether or not they complete their evaluation because they may not 
understand the importance of it.” Another transplant coordinator shared: 
“Um, that seems to be an issue sometimes, they just, some people just don’t seem to 
really get it, you know, understand why it’s important or why they’re going to benefit 
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from it. Um, and I guess you do see that kind of more often in people that don’t have as, 
as high of an education level.” 
Subtheme (b): Access to information about transplantation. Transplant professionals 
reported that some patients do not have access to information about transplantation. They may 
not have access to the Internet to read about transplantation or they are unable to access 
information about transplantation from their social networks. Other patients may not know how 
to obtain information about transplantation or kidney disease. A transplant coordinator reported: 
“Um, possibly more so with the older ones I guess because, you know, they don’t have 
the computer skills that younger people do. You know, younger people it doesn’t matter 
what ethnicity, you know what I’m trying to say. Um, you know, they know about 
computers and how to look for information if they wanted and I guess maybe because we 
do have a higher, uh, percentage of African Americans that you do see that more 
commonly with them, especially in the older ones that don’t surf the web and, you know, 
look up information.” 
Subtheme (c): Transplant education. Many transplant professionals discussed the fact 
that patients are presented with high volumes of information during their evaluation and the 
information is not always catered to their understanding. An example of this can be seen in this 
excerpt from a transplant coordinator: “…They receive a lot of education on their first visit and 
no one could humanly really retain all of that so as coordinators we do kind of follow up.” 
Subtheme (d): Limited knowledge of the medical evaluation and/or transplantation. 
Patients without knowledge of the benefits of transplantation over sustained dialysis or those 
who do not know the purpose of the medical evaluation process face barriers in completing their 
evaluation. This is reflected by the following quote from a nephrologist: “… Yeah, I think 
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understanding the importance of the test and understanding where they are in the transplant 
process and why they have to complete the tests, and the benefits of transplants.”  
Theme 3: Systemic barriers. Systemic barriers, or barriers at the hospital level, were the 
third most frequently identified barrier to patients’ completion of the medical evaluation for 
transplantation. Transplant professionals reported that patients experience these barriers because 
of referral processes and scheduling difficulties, and struggle to navigate their way around a 
large hospital.  
Subtheme (a): Healthcare logistics. Patients have a difficult time navigating the 
healthcare system including finding a doctor’s office or trying to find their way around large, 
complex hospital campuses. One social worker speculated that navigating unfamiliar hospital 
settings may be intimidating for patients: “…um, the hospital, uh, a large university hospital in 
the inner city can be very intimidating for them.” 
Subtheme (b): Transplant-specific problems. Some patients are not referred for transplant 
or there is a delayed referral by their general nephrologist. Since there is no central testing 
location, patients must attend several doctors’ appointments, sometimes at different locations. 
Scheduling multiple appointments around ongoing dialysis treatments presents additional 
difficulties. Further confusion arises when breakdowns in communication between the transplant 
professionals and patients occurs. A nephrologist stated, “…Uh they’ll see different providers 
even in their own facilities, different nephrologists…they might not get referred early so they 
might develop a lot more disease by the time they get to see us…” 
Theme 4: Health-related barriers. Health-related barriers were the fourth most named 
barrier to completion of the medical evaluation process. Barriers that fall under this category 
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include the patient presenting with multiple health conditions or comorbidities; prolonged 
dialysis use, which may make the patient more ill; and weight issues.  
Subtheme (a) Comorbidities. Patients with multiple health conditions, in addition to 
ESRD (e.g., cardiovascular disease), experience delays because considerably more tests are 
required to progress through the evaluation process. In some instances, patients must also be 
deemed clear of the condition before being allowed to complete the evaluation process. A 
transplant coordinator stated: 
“Um, heart disease, if they have, um, severe heart disease. Um, calcification in the 
vessels where the kidney would attach that could prevent someone from being able to 
receive a transplant. Um, you know we just have to make sure that in general they’re 
going to become better, not worse, from the transplant. So if they have multiple 
comorbidities it may not be a good idea for them. So, a lot of times it’s heart disease.”  
Subtheme (b) Health status. Dialysis is a physically demanding therapy leaving many 
patients exhausted and physically ill, limiting the ability to keep appointments as scheduled. 
Further, prolonged dialysis is associated with both physical and psychological problems such as 
fatigue, depression, decreased quality of life and heart disease (Christensen & Ehlers, 2002, 
Heerspink et al., 2009; Jhamb, Weisbord, Steel & Unruh, 2008). In general, most ESRD patients 
have poor health because of their disease. This excerpt from a transplant coordinator exemplifies 
this subtheme: 
“So, because if somebody isn’t feeling well then that, that person might just say, you 
know, I can’t go to (transplant center) today and sit there for, like, three hours. That’s 
health status, and it can, but it can mean a lot of different things, as much as, you know, 
not feeling well. But there could also be complications, um, with dialysis. You know 
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maybe they have, they’re planning to do dialysis early in the morning and something 
went wrong.”   
Subtheme (c): Health requirements. Patients with BMI above 30 are required to lose 
weight before being released to complete the medical evaluation. Similarly, patients with severe 
mental illness and substance use may be required to seek treatment, be medically stable, or be 
drug free before they can complete the evaluation. A nephrologist reported:  
“Um, I think if people aren’t being properly treated for their mental health issues they 
don’t… I think mental health, you have to come back and meet with a psychiatrist as well 
too, with an extra layer to it. Um, and if someone’s depressed, then they don’t want to go 
to their test. And so, I think it’s untreated mental health, let me re-phrase that. Um, and 
then the other thing is substance abuse you know. I think that’s a major impediment. You 
have these functional drug abusers as well. People who use cocaine but are still 
functional, to the sense that, I mean, functional in a sense that they have End Stage Renal 
Disease and cocaine probably contributed to it but they’re not, you know, they’re still 
married, they still live in a house, they have kids who want to donate kidneys to them but 
keep coming back positive for cocaine. Well, you know, they’re the model dialysis 
patients, that all their labs are perfect, they never miss a dialysis treatment, but they keep 
getting disqualified because of their positive drug, and even marijuana as well too, and a 
lot of patients use marijuana to help them with the nausea associated with the dialysis, so 
that becomes it, but those are really the major two things…” 
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Patient-identified Barriers to Completion of the Medical Evaluation  
 Thematic analyses were conducted to address RQ4: identifying patients’ perceptions of 
barriers to completing the medical evaluation process. These themes are presented here, in 
descending order, beginning with most frequently reported barriers.  
Theme 1: Individual-level barriers. Similar to transplant professionals, patients were 
most likely to report individual-level barriers. The majority of these barriers were socioeconomic 
in nature, such as limited income, impacting the cost of medications and access to transportation. 
Additionally, insurance issues and limited social support were indicated as contributing to 
socioeconomic difficulties. Some patients also mentioned time constraints in trying to fit their 
medical appointments in with their dialysis schedule and other activities such as work and 
childcare. Further, difficulties finding a living donor also served as a barrier. Some patients 
reported that lack of motivation or fears (e.g., about losing benefits after transplant, undergoing 
the transplant surgery) impede completion of the medical evaluation process. A few patients 
attributed difficulties in completing the evaluation process to medical mistrust. The following 
excerpts reflect this theme:  
Male patient: “…That’s one things I have a problem with, if I go through with the 
transplant, that’s the only things I’m going to have problem with all my appointments because 
my mother doesn't drive, my two sisters refuse to drive in the city because they two country girls.  
They will not drive in (city), and I don’t think I'm going to be able to drive so I have to find 
somebody to bring me back and forth.”  
Male patient: “…As far as with you, man, when I get my transplant I don’t got nobody to 
take care of me. Um, how can I get some assistance with this, you know what I'm saying? 
Because I'm by myself …”  
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Female patient: “…You know there’s, um, the financial aspect of it, um, of getting a 
transplant, the funding of it, um, you know because even with insurance you still, um well, 
sometimes if you have insurance and social security or Medicare then usually you’re pretty good 
but there’s a copay if you just have insurance so it’s still a big financial responsibility that you 
end up…”  
Female patient: “…Well, you have to make sure the donor is a match obviously. Um, and 
it’s hard to get a donor. No one wants to go through it and, um, uh it’s just a hard process…” 
Male patient: “… like you get a kidney and you’re off disability but what if I'm just not 
ready. Ok, and then nobody says ok, and I know how things work because they’ll say, well, you 
got a kidney and you’re fine, well, ok you’re saying I'm fine but what if I’m not fine you know 
who’s to make that judgment to say your finances should be cut off…”  
Theme 2: Systemic barriers: In contrast to transplant professionals, systemic barriers 
were the second most commonly identified barrier among patients. The barriers were mostly 
transplant-specific problems that related to poor communication between the patients and 
transplant staff; scheduling difficulties; having to work with several doctors; long wait times for 
doctor’s appointments and test results; and, not having access to transplant coordinators. Further, 
some patients also reported systemic barriers related to healthcare logistics such as difficulty 
finding their way around the hospital, parking issues, and construction. The following examples 
illustrate this theme: 
Female patient: “It takes a long time for some of them, some people have to have sleep 
studies, it could take you up to four months to get an appointment for a sleep study, so it’s a lot 
of stuff and there is a check list, so you have to get this done.”  
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Male patient: “…The transplant coordinators, they aren’t very communicative, that’s the 
one part I would probably say could use some improving. I mean, I’ve called them sometimes 
just to find out where things are and, um, many times I haven’t got a call back, um, from 
them…I know they are probably busy but they could do a little more communicating…”  
Female patient: “It’s a lengthy process to actually get onto the transplant list.”  
Male patient: “…uh, the only thing I, it was just hard finding my way around (hospital). 
They had a parking deck that I end up going backward...”  
Theme 3: Health-related barriers: Health-related barriers were the third most identified 
barriers to completing the medication evaluation by patients. Patients reported subthemes related 
to having health conditions other than kidney disease, health status, and health requirements. 
Some patients also reported being fatigued, while others mentioned that they had not been 
cleared from psychiatry. The quotations below reflect this theme: 
Female patient: “Well mine’s is not just a kidney, uh, disease. Um, I guess you could 
kinda say I have another illness. Um, my illness is, I don’t know if you ever heard of it, 
it’s called tubular sclerosis. And I think I got the complex, which means like the tumors 
that’s on my face, it grows on my kidney. And that’s what the doctor, uh, was sayin’ and 
that the tumors had grew on my kidney where was messing with the function of my 
kidney. So, you know, those two is kinda, you know, together.”  
 
Female patient: “I would say I am really tired all the time, like never before. I just don’t 
have energy to do too much of anything. Tired and also with all the medication I take 
‘cause I have a chronic hypertension problem so I am on, like, five different blood 
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pressure meds… But I just don’t feel like doing anything anymore. That’s the worst part 
of all of this. I lay down a lot.” 
Male patient: “Mine is fatigue, my energy level is not what it used to be, you know, um, 
and I guess, like, from a mental stand point one of the things that, uh, kind of messed 
with me is, you know…”  
Female patient: “Um, my problem was with the psychiatry because I’ve been under stress 
and not only from that but other stuff and I had to go every week, every Tuesday. I got a 
lot of problems from fibromyalgia so I don’t sleep at night, I take a lot of medication for 
it but I be in a lot of pain so …9’oclock every Tuesday, they had me going to psychiatry 
and I just stopped going.”  
Theme 4: Informational/educational barriers. Limited information/education was the 
fourth most reported barrier to completing the medical evaluation. Patients expressed that they 
would have liked more information about transplantation, especially the medical evaluation 
process, the number of tests and medical procedures required, and the financial aspects of getting 
a transplant. The following quotes exemplify this theme:  
Male patient: “Um, well, I wish they would have, um, or somebody would have told me a 
little bit more ‘cause, be honest, I didn’t know nothing about tests and stuff. All they just 
told me is that I am on the list, and um, be ready when they call me, you know. If I get a 
transplant. And you know, that was it. They didn’t really give me much information and, 
you know, they should have told me that I had to go through tests and stuff.”  
Female participant: “We don’t know all of the procedures that need to be done so we 
can’t make that call as to, okay, what needs to be done? You know, it’s ever changing. 
You know. If you need more blood work, let us know. You know, because the worse 
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thing is you come up here for an appointment, procedure or whatever, and they say, ‘Oh, 
Ms. X, you haven’t had this done. Why weren’t you here for this appointment?’ And you 
had no idea it was there. You know. You don’t want to be surprised.”  
Transplant Professionals’ Identified Motivators to Completion of the Medical evaluation  
 RQ2 was addressed by identifying transplant professionals’ perceptions of motivators, 
encompassed by the following themes:  
Theme 1: System-level motivators. The majority of the motivators identified were 
system-level. Transplant professionals indicated that specific structural changes in the hospital 
and transplantation system could impact African Americans’ completion positively. The 
facilitators include: greater referrals from local nephrologists; patient navigators and/or case 
management staff; physician repertoire (i.e., the physician’s ability to build rapport with the 
patient); compressed time frame for medical testing; and comprehensive insurance for patients. 
A nephrologist commented that, “I think removing the intimidation aspect of things that comes 
with the medical system. Trying to work, and I think this goes across racial barriers, trying to 
work with their schedule rather than imposing, this must be done by this day and stuff like 
that…”  
Theme 2: Informational/educational motivators. The second most identified motivator 
reported by transplant professionals were informational/educational factors. These include 
center-based education about the evaluation process, formal education, presenting information in 
lay terms, education of nephrologists, promotion of transplantation, and continued education 
about transplantation. One nephrologist stated, “Constant education of the patient so far as the 
patient’s education and comprehension level, you want the patient to be able to comprehend 
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really quickly as to why they’re not taking their medication and sometimes if they don’t but as 
long as you lay out the guidelines, they’ll still be okay as long as they follow your instructions.” 
Theme 3: Individual-level motivators. The third most reported type of motivator 
identified by transplant professionals impacted patients at the individual level. These include 
patients’ desire to get off dialysis and have a better quality of life, patients’ religious beliefs or 
faith, and knowledge of a successful transplant recipient. The following excerpt from a transplant 
professional reflects this theme: 
“…they also see that in their dialysis unit, you know, people are dying or getting their 
limbs amputated and they don’t want to be in that situation. They also see patients in the 
dialysis unit getting a kidney transplant coming back to dialysis unit doing well after a 
kidney transplant, so that is a big motivating factor for a lot of patients. I think the 
number one motivation is, the number one answer I get is that I can’t deal with dialysis 
anymore, but I think they do realize though because it just drains you so much, they can’t 
do anything else the rest of the day. But they also realize the health benefits to that…”  
Solutions identified by transplant professionals. Solutions proposed by transplant 
professionals include: removing intimidating factors in transplantation, better case management, 
comprehensive insurance, improving access to primary care, pre-dialysis treatment, working 
with the patients to problem solve, creating programs to motivate or empower patients, and more 
education about transplantation and the evaluation process.  
Patient-identified Motivators to Completion of the Medical Evaluation  
 To address RQ5, themes representing patient-identified motivators to completing the 
medical evaluation were grouped into the categories below. 
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Theme 1: Individual-level motivators. The majority of the motivators identified were 
individual-level facilitators to transplant completion. Included in this category was family 
support, such as financial support from family members, support from the transplant staff, 
patients’ desire to get off dialysis, and belief systems such as spiritual or religious beliefs. The 
following quotes illustrate this theme: 
Female patient: “… My co-pay was $853 a month, and at the end, the last six months it 
was almost $900 a month, however, because God is good, and I have a good brother, he actually 
paid my co-pay for me for a total of a little over $10,000 over a 18-month period because I was 
unemployed, no income…”  
Male patient: “…I mean, if it wasn’t for my wife, I give her all the praise for, uh, pushing 
me to go to my appointments and, you know, doing everything I was supposed to, it makes the 
process a lot easier…you need somebody.”  
Male patient: “Maybe providing transportation…”  
Theme 2: Systemic motivators. The second most identified type of motivator to 
completing the medical evaluation was systemic. These included good communication with the 
transplant coordinators, updates on the patient’s position on the waitlist, appointment reminders, 
decreasing the intervals between doctor’s appointments, and rehabilitation support for patients 
without social support. This theme is evident in the following quote given by a female patient: 
“… I mean, the coordinators have folks to help them (patients) too. They have financial 
coordinator and a social worker. Their own staff that works for the transplant office. You 
know, and both of those folks can help you if you have financial issues to get your 
medication or to get your transplant. And it’s a good thing to do to talk to them before to 
see what your financial outlook looks like as far as, you know, even with insurance.”  
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Theme 3: Informational/educational motivators. Patients reported 
informational/educational motivators least frequently. These include education about 
transplantation, specifically the medical evaluation, providing information that is easy to 
understand, and knowing a successful transplant recipient. This lack of information is embodied 
in the response of one male patient, “Yeah, yeah, I guess if they expect you…why these number 
of tests are being done in order to get on the list...you know, why do you need to test that many 
to get on the list...um, I guess.”  
Group Differences in Identified Barriers 
 Group differences among transplant professionals’ identified barriers. To help 
address RQ3, differences in transplant professionals’ perceptions of barriers were examined. 
Specific to barriers, nephrologists reported the most barriers to completing the medical 
evaluation process in comparison to transplant coordinators, social workers, and psychologists. 
Social workers and psychologists were more likely to address the psychosocial factors associated 
with completion of the medical evaluation, such as problems with social support, financial 
barriers and problems with substance use or severe mental illness. Nephrologists and transplant 
coordinators were also more likely to report individual-level barriers relative to transplant 
coordinators, social workers, and psychologists. 
Status differences among patients’ identified barriers. To help address RQ8, Status 1 
and Status 7 patients’ reports of barriers were compared. Status 1 patients reported fewer barriers 
to completing their evaluation and at times had difficulty identifying any roadblocks as 
compared to Status 7 patients.  
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Group Differences in Identified Motivators 
Group differences among transplant professionals’ identified motivators. To help 
address RQ3, group differences in perception of motivators by the different types of transplant 
professionals were examined. Nephrologists were more likely to report systemic and individual-
level motivators relative to transplant coordinators, social workers, and psychologists. In 
contrast, transplant coordinators were more likely to propose information/educational-related 
solutions whereas nephrologists proposed systemic solutions. Social workers and psychologists 
reported more socioeconomic solutions to completing the medical evaluation process in 
comparison to the other professionals.  
Status differences among patients’ identified motivators. To help address RQ8, 
differences between Status 1 and Status 7 patients’ reports of motivators were examined. Status 1 
patients reported more social support, no transportation difficulties, and minor insurance issues. 
Both groups reported support from the transplant staff. 
Rankings for Barriers to Completing the Medical Evaluation  
 Twenty-one barriers reported by transplant professionals were prioritized as impeding 
completion of the medical evaluation process to help address RQ1. These barriers were further 
categorized into individual-level, systemic, health-related and informational/educational barriers. 
The majority of the barriers (42.86%) prioritized impact the patient at the individual level and 
consisted primarily of socioeconomic difficulties. Six informational/education level barriers 
(28.57%), four systemic barriers (19.05%), one health-related barrier (4.76%), and another was 
categorized as both a health and systemic barrier (4.76%). The top five barriers identified were: 
limited income/low SES, lack of a personal means of transportation, limited/lack of patient 
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motivation, insurance issues, and the number of procedures and/or tests required to complete the 
evaluation (see Table 4).  
To address RQ6, for patients, 36 barriers were ranked and assigned priority scores, with 
individual-level barriers (44.44%), systemic barriers (33.33%) and health-related barriers 
(11.11%), informational/educational barriers (5.56%), one classified as both a health and 
systemic barrier (2.78%), and another as both an individual-level and systemic barrier (2.78%). 
The highest ranked barriers were insurance issues, scheduling difficulties, lack of a personal 
means of transportation, time constraints that make it difficult to complete several medical 
procedures/tests, and limited income/low SES (see Table 5).  
 
Table 4 
Transplant Professionals’ Rankings of Barriers to Completing the Medical Evaluation 
______________________________________________________________________________ 
Top Barriers      Total   Max Priority  n of  
                                                                                    Score   Score (%) participants  
                                                                                                                                    ranking this 
                                                                                                                                    their Top 5  
 
1. Limited income/Low SESa    52  45.22  15  
2. Lack of personal means of transportationa  40  34.78  11   
3. Limited/ lack of patient motivationa  38  33.04  11   
4. Insurance issuesa     33  28.70  11   
5. Number of procedures and/tests required to 32   27.83  12 
    complete the evaluationcd 
6. Multiple health conditionsd    31  26.96  11 
7. Lack of understanding of the informationb  27  23.48  10 
    provided during the medical evaluation 
8. Limited knowledge of the benefitsb  24  20.87  7 
    of transplantation 
9. Inability to pay for out-of-pocket costs   21  18.26  7 
    associated with the evaluationa 
10. Limited health literacyb    17  14.78  7 
11. Distance to transplant from patient’s   12  10.43  6 
      housea   
12. Limited information about the medical  9  7.83   3 
      evaluation processb 
13. Religious beliefsa     4  3.48  1 
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14. Racial discriminationc    3  2.61  1 
15. Medical mistrusta     2  1.74  2 
 
Other barriers          Count  
16. Lack of care partner supportc   *  *  1 
17. Limited formal education    *  *  1 
18. Limited/lack of social supporta   *  *  2 
      (especially lack of family support)     
19. No localized testingc    *  *  1 
20. No primary care physicianc   *  *  1 
21. Poor comprehension of reading materialsb *  *  1 
 
Note. N =23. The maximum possible priority score was 115. Priority scores were not calculated 
for other barriers (not in the top 5) indicated by transplant professionals. aIndividual-level barrier, 
bInformational/educational barrier, cSystemic barrier and dHealth-related barrier. 
 
 
 
 
Table 5 
Patients’ Rankings of Barriers to Completing the Medical Evaluation  
______________________________________________________________________________ 
Top Barriers      Total   Max Priority  n of  
                                                                                    Score   Score (%) participants 
                                                                                                                                    ranking this  
                                                                                                                                    in their Top 5  
 
1. Insurance issuesa     32  24.62  9  
2. Scheduling difficulties (e.g., gettingc  19  14.62  5 
    an appointment for some tests takes a while)    
3. Time constraints that make it difficult toa   19  14.62  4  
    complete several medical procedures/tests       
4. Lack of a personal means of transportationa  16  12.31  4   
5. Limited income/Low SES (including difficultya  11  8.46  3 
    covering the cost of medications) 
5. Finding a living donora    11  8.46  3 
6. Length of time to complete the medicalc  9  6.92  2 
    evaluation (e.g., time spent waiting for tests) 
6. Medical complications (e.g., infections, health  9  6.92  2 
    problems)d 
7. Poor communication with the transplant centerc 8  6.15  2 
8. Length of time spend at the transplant center 7  5.38  2  
      (i.e., long appointment days)c    
8. Limited/lack of social support (i.e., froma   7  5.38  2 
      family and friends)     
8. Number of procedures and/tests required to 7  5.38  2 
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    complete the evaluationcd  
9. Difficulties with the stress testc   7  5.38  2 
10. Limited/lack of patient of motivationa   6  4.62  2 
10. Multiple health conditionsd   6  4.62  2 
11. Concerns about kidney rejection after   5  3.85  1 
      transplantationa  
11. Concerns about losing financial support after  5  3.85  1 
      transplantationa 
11. Poor physician rapportc     5  3.85  1 
11. Having to complete medical procedures/tests 5  3.85  1 
      at another facilityc  
11. Limited/lack of family involvement in the  5  3.85  1   
      evaluation process ac     
11. Issues with medical compliancea    5  3.85  1 
11. Medical readjustmentsd    5  3.85  1   
11. Multiple medical procedures/tests in one dayc 5  3.85  1   
11. Not knowing whether the medical procedures/ 5  3.85  1   
      tests would disqualify patient from being  
      placed on the waitlista 
11. Poor physical health (i.e. feeling sick)d  5  3.85  1   
11. Smoking cessationa     5  3.85  1  
11. Wait time for a deceased organc   5  3.85  1   
11. Waiting for information about the   5  3.85  1   
      evaluationb  
12. Concerns about taking medicine for the  4  3.08  1  
      rest of the patient's lifea  
12. Medical mistrusta     4  3.08  1 
12. Navigating a large hospital (e.g. parking  4  3.08  1   
      difficulties, construction)c 
13. Fear of going to the dentista   3  2.31  1 
13. Lack of communication between the dialysis 3  2.31  1 
      unit and transplant centerc 
13. Length of time it takes for tests results to get to 3  2.31  1 
     the transplant centerc 
14. Limited information about financial aspects of  1  0.77  1 
      the evaluationb  
14. Difficulty maintaining social support   1  0.77  1 
      throughout process a 
Note. N = 26, four participants did not provide rankings. The maximum possible priority score 
was 130. Priority scores were not calculated for other barriers (not in the top 5) indicated by 
patients. aIndividual-level barrier, bInformational/educational barrier, cSystemic barrier and 
dHealth-related barrier. 
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Rankings for Motivators to Completing the Medical Evaluation  
 To help address RQ2, thirteen motivators identified by transplant professionals were 
ranked and assigned priority scores. The majority of the motivators prioritized were systemic in 
nature (38.46%), four were informational/educational motivators (30.77%), two were individual-
level (15.38%), and the remainder were a combination of both individual-level and systemic 
motivators (15.38%). The top five motivators were center-based education about the evaluation 
process, instrumental support (e.g. help with childcare and transportation), patients’ knowledge 
of the benefits of kidney transplantation over sustained dialysis, the availability of patient 
navigators, and informational support about kidney transplantation (see Table 6).  
To address R7, fifty-four motivators identified by patients were prioritized as facilitating 
completion of the medical evaluation process. These motivators were classified into individual-
level motivators (38.89%), informational/educational motivators (25.93%), systemic motivators 
(29.63%), and combinations of individual-level, systemic and informational/educational 
motivators (5.55%). Patients ranked their top five motivators as social support, religious beliefs, 
more information about the medical evaluation process, support from the transplant staff, and a 
desire to get off dialysis (see Table 7).  
 
Table 6 
Transplant Professionals’ Rankings of Motivators to Completing the Medical Evaluation 
______________________________________________________________________________ 
Top Motivators     Total   Max Priority  n of                     
                                                                                    Score   Score (%) participants  
                                                                                                                                    ranking this in 
                                                                                                                                    their Top 5  
 
1. Center-based education about the evaluation  59  53.64  18 
    processb     
2. Instrumental support (e.g. having assistance  56  50.91  17 
    with childcare and transportation) ac    
3. Knowledge of the benefits of kidney  49  44.55   14 
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    transplantation over sustained dialysisb       
4. Patient navigatorsc      46  41.82  15   
5. Informational support (i.e. having people who 40  36.36   15  
    are knowledgeable of transplantation in one’s 
    social network)ac 
6. Physician investmentc    25  22.73  9   
7. Emotional support and counselingac  19  17.27  8   
8. Comprehensive insurancec    19  17.27  7 
9. Formal educationb     11  10  4   
10. Exposure to diverse cliniciansc    5  4.55  2   
11. Exposure to media promotion of thec  1  0.91  1    
      benefits of kidney transplantation  
 
Other motivators         Count  
12. Ability to cover out-of-pocket costsa  *  *  1 
13. Motivation to return to worka   *  *  1 
 
Note. N = 22, one participant did not provide motivator rankings. The maximum possible priority 
score was 110. Priority scores were not calculated for other motivators (not in the top 5) 
indicated by transplant professionals. aIndividual-level motivator, bInformational/educational 
motivator, cSystemic motivator and dHealth-related motivator. 
 
 
 
Table 7 
Patients’ Rankings of Motivators to Completing the Medical Evaluation 
______________________________________________________________________________ 
Top Motivators     Total   Max Priority  n of  
                                                                                    Score   Score (%) participants              
                                                                                                                                    ranking this 
                                                                                                                                    in their Top 5  
 
1. Social support (i.e., support from family  34  27.2  10 
    and friendsa      
2. Religious beliefsa      21  16.8  5   
3. More information on the evaluation  19  15.2  4 
    (e.g., what to expect, why it could take      
     about a year to complete) b        
4. Support from transplant staff (e.g.,   14  11.2   5 
   doctors, coordinators, social workers) c 
5. Desire to get off dialysisa     13  10.4  3 
6. Knowing a successful transplant    10  8  4 
    recipientb    
7. Good communication with transplant   10  8  2    
    staff (especially pre-transplant coordinators)bc  
8. Follow up by transplant staff (including   9  7.2  2    
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    calls notifications/reminders for upcoming  
    appointments, what to expect, what's next)c 
9. Motivation to return to worka    7  5.6  2 
10. Knowing the medical procedures/tests  6  4.8  2 
      involved in the evaluation processb  
11. Explaining information in manner that  5  4  2 
      facilitates understandingb  
11. Financial assistance (e.g., to help with  5  4  2 
      the cost of medications)c 
12. Decreasing the intervals between doctors'  5  4  1 
      appointmentsc 
12. Desire to live because of family    5  4  1 
     (e.g. desire to live for children) a 
12. Follow up appointments after medical   5  4  1 
      procedures/tests are completedc    
12. Knowledge of transplantationb   5  4  1 
12. Hearing stories from former kidney patientsa  5  4  1 
12. Patient motivationa     5  4  1 
12. Personal means of transportation without  5  4  1 
      relying on othersa 
12. Providing reading information about kidney  5  4  1 
      transplantation for the patient to take homeb 
12. Rehabilitation support for patients without  5  4  1 
      social support after transplantation c  
12. Support from dialysis center c   5  4  1 
13. Education about how to maintain contact  4  3.2  1  
      with pre-transplant coordinatorsb 
13. Comprehension of the evaluation processa 4  3.2  1  
13. Increased information sharing    4  3.2  1 
      (between patients)b 
13. Kidney support groupsc    4  3.2  1 
13. Knowing social workersa    4  3.2  1 
13. Patient's desire to live longera   4  3.2  1 
13. Support from primary care physicianc  4  3.2  1 
14. Support from specialistsc    4  3.2  1 
15. Communication between dialysis and  3  2.4  2  
      transplant centersc 
15. Education about the benefits of    3  2.4  2 
      transplantationb 
15. Improved scheduling of medical appointmentsc 3  2.4  2 
15. Being able to ask questionsa   3  2.4  2 
15. Continuous education as patients go through 3  2.4  2 
      the medical evaluation processb 
15. Desire for better healtha    3  2.4  2 
15. Knowing that kidney transplant is nearab  3  2.4  2 
15. Meeting doctors and nursesa   3  2.4  2 
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15. More Information about the transplant surgeryb 3  2.4  2 
15. Physician repertoirec    3  2.4  2 
15. Support from primary nephrologistc  3  2.4  2 
15. Updates on position on the waitlistb  3  2.4  2 
16. Desire to resume recreational activities   2  1.6  1 
      (e.g. travel) a 
16. Improved access to social workers and   2  1.6  1 
      financial coordinators c 
16. Information on how to raise funds to help with 2  1.6  1 
      financial costs associated with evaluationb 
16. Patience (from patient) a    2  1.6  1 
16. Seeing other peers (i.e. patients in the same 2  1.6  1 
      age group) in bad healtha 
16. Support and information groupsbc  2  1.6  1 
17. Change in patient’s perspective of diseasea 1  0.8  1 
17. Focus group (from the current study)a  1  0.8  1 
17. Patient navigatorsc    1  0.8  1 
17. Occupational supporta    1  0.8  1 
 
Other motivators          Count  
17. Having a living donora    *  *  1 
18. Knowledge of patient expectationsb  *  *  1 
Note. N = 25, five participants did not provide motivator rankings. The maximum possible 
priority score was 125. Priority scores were not calculated for other motivators (not in the top 5) 
indicated by patients. aIndividual-level motivator, bInformational/educational motivator, 
cSystemic motivator and dHealth-related motivator. 
 
Between-Group Differences and Similarities in Top Barriers in Rankings 
Transplant professionals and patients similarly rated limited income/low SES, insurance 
issues and lack of a personal means of transportation in their list of top five barriers. From the 
perspective of transplant professionals, limited or lack of patient motivation and the number of 
procedures and/or tests required during the pre-transplant evaluation are among the top five 
barriers. Alternatively, patients listed scheduling difficulties and time constraints. Synonymous 
rankings and differences between transplant professionals and patients in top five barriers are 
depicted in Figure 3.  
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Figure 3. Differences and Similarities between participant rankings of the top five barriers to 
completing the medical evaluation process.  
 
Between-Group Differences and Similarities in Top Motivators in Rankings 
Transplant professionals listed center-based education, patients’ knowledge of the 
benefits of transplantation over sustained dialysis and patient navigators as top motivators to 
completing the evaluation process. In contrast, patients listed scheduling difficulties and time 
constraints. Synonymous rankings and differences between transplant professionals and patients 
in the top five motivators are depicted in Figure 4.  
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Figure 4. Differences and Similarities between participant rankings of the top five motivators to 
completing the medical evaluation process.  
 
Group Rankings of Top Five Barriers  
Patients who participated in the focus groups included poor communication with the 
transplant center and difficulty finding a living donor in their top five rankings. The top five 
group rankings of barriers by focus group patients are displayed in Table 8. 
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Table 8 
Patient Group Rankings of Barriers to Completing the Medical Evaluation 
______________________________________________________________________________ 
Top    Barriers Total   Number of   Weighted  
                                                                         Score   Focus Groups/  Total (%)  
                                                                                                n of participants                                     
  
1. Insurance issues     20  6 (13)   36.36  
2. Limited income/low SES    12  3 (8)   21.82  
3. Poor communication with the    9  2 (6)   16.36 
    transplant center   
4. Length of time to complete the   8  3 (9)   14.55 
    medical evaluation (e.g., for    
    appointments, for results)       
5. Finding a living donor     6  2 (5)   10.91 
 
Note. N = 22. Priority scores were calculated based on group consensus of the five top barriers 
elicited during the NGT focus groups (i.e., 1st = 5 points, 2nd = 4 points, 3rd = 3 points etc.) and 
expressed as a percentage of the weighted total of scores (55).  
 
Group Rankings of Top Five Motivators 
 Focus group participants counted financial assistance throughout the evaluation process 
and information about the medical evaluation process (e.g., financial and psychosocial 
information). The top five group rankings of motivators are displayed in Table 9.  
 
Table 9 
Patient Group Rankings of Motivators to Completing the Medical Evaluation 
______________________________________________________________________________ 
Top Motivators   Total  Number of   Weighted  
                                                                        Score   Focus groups/   Total (%)                                    
         n of participants 
  
1. Social support    18  5 (11)   32.14 
2. Information about the medical  
    evaluation process (including financial 10  2 (6)   17.86  
    and psychosocial-related information) 
3. Religious Beliefs    10  2 (4)   17.86   
4. Financial assistance throughout the 9  3 (9)   16.07   
    evaluation process 
5. Support from dialysis center  9  2 (6)   16.07   
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Note. N = 22. Priority scores were calculated based on group consensus of the five top motivators 
elicited during the NGT focus groups (i.e., 1st = 5 points, 2nd = 4 points, 3rd = 3 points etc.) and 
expressed as a percentage of the weighted total of scores (56).  
 
 
Differences in focus group rankings of barriers based on patient status. To help 
address RQ8, Status 1 and Status 7 patients’ group rankings were compared. Both Status 1 and 7 
patients reported insurances issues in top five barriers. Status 1 patients also reported scheduling 
difficulties, medical complications, multiple health conditions, and navigating a large hospital. In 
contrast, Status 7 patients reported limited income/low SES, poor communication with the 
transplant center, difficulties finding a living donor, and lack of social support.  
Differences in focus group rankings of motivators based on patient status. To help 
address RQ8, Status 1 and Status 7 patients’ group rankings were compared. Both Status 1 and 7 
patients reported social support in top motivators. Status 1 patients also religious beliefs, support 
from transplant staff, motivation to return to work and a personal means of transportation 
without relying on relying on others. In contrast, Status 7 patients reported financial assistance 
throughout the evaluation, information about the medical evaluation process, knowing a 
successful recipient, and support from the dialysis center. 
Summary of Barriers and Motivators and Possible Solutions  
A summary of the top barriers, motivators and possible solutions to improve completion 
rates of the medical evaluation project was developed in an attempt to combine the qualitative 
and quantitative elements of this project. Table 10 provides a snapshot of the findings from both 
transplant professionals and patients.  
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Table 10  
Summary of Top Barriers, Motivators and Possible Solutions  
 
Top Barriers  Motivators/Possible Solutions  
Insurance issues • Comprehensive Insurance  
• Information about financial aspects of the 
evaluation (e.g., insurance paperwork) 
• Support from the transplant staff 
especially financial coordinators 
Limited income/low SES • Financial assistance  
• Information on how to raise funds to help 
with financial costs  
• Support from social workers and financial 
coordinators 
• Family member assistance with costs of 
completing the evaluation  
Lack of a personal means of transportation • Instrumental social support  
• Comprehensive insurance that includes 
transportation  
Limited/lack of patient motivation • Creating programs to motivate or 
empower patients 
• Kidney support groups  
• Hearing the stories of kidney recipients  
• Patient navigators  
The number of procedures and/ 
tests required 
 
• Informational support  
• Center-based education about the medical 
evaluation process and kidney 
transplantation 
• Education catered to patient’s 
understanding  
• Centralized testing  
Scheduling difficulties/Time constraints • Case management  
• Good communication between patients 
and transplant center  
• Liaisons between transplant center and 
dialysis center  
 
 
Correlations 
 Transplant professionals’ ratings of perceived barriers and motivators indicated a number 
of positive associations (see Table 11). This analysis was performed to determine whether certain 
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barriers and motivators were related to each other. Based on Cohen’s (1998) interpretations, the 
strength of these relationships ranged from moderate to large (r values ranged from .44 to .68). 
For example, there was a positive relationship between income and knowledge of treatment 
options, knowledge of the medical evaluation, health literacy and navigators, with strengths 
ranging from moderate to large. Similarly, patient ratings of barriers and motivators revealed 
several positive associations (moderate to large; r values ranged from .37 to .72) (see Table 11). 
There was a positive relationship between income and distance to the center, comorbidities, 
being on dialysis, health literacy and instrumental support. The strength of these relationships 
were moderate to large.  
Ratings for both transplant professionals’ and patients’ perceived barriers and motivators 
to completing the medical evaluation process were also examined for associations (see Table 12). 
There was a positive relationship between distance from the patient’s house to the transplant 
center, and income, comorbidities, and instrumental support. The strength of these relationships 
was large (r values ranged from .53 to.64). Knowledge of treatment options for kidney 
transplantation was also positively related to knowledge of the medical evaluation process, 
comorbidities, religious beliefs, and being on dialysis (r values ranged from .50 to .63). 
Knowledge of the medical evaluation process was positively associated with health literacy, 
comorbidities, navigators and having instrumental support (r values ranged from .52 to .63). 
Furthermore, health literacy was positively related to medical mistrust, navigators, and having 
instrumental support (r values ranged from .53 to .67). The two motivators, having navigators 
and instrumental support, were also positively related (r =.67). Income level and being on 
dialysis was also positively associated (r =.53). The majority of the other associations were 
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moderately positive (r values ranged from .30 to .49) and the rest were small (r values ranged 
from .28 to .29) (see Table 12). 
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Table 11 
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for Transplant Professionals 
____________________________________________________________________________________________________________ 
      1 2 3 4 5 6 7 8 9 10 11 12   
 
1. Insurance status    -         .68** .06 -.20 .04 .41 .20 .29 .36 -.02 .34 .42* 
2. Income     - - .41 .16 -.05 .48* .53** .30 .44** .02 .58** .30 
3. Distance to center     - - - .46* .18 .11 .25 .12 .27 .03 .13 .10  
4. Comorbidities    - - - - .20 .27 .28 -.001 .20 -.04 .19 .32  
5. Religious beliefs    - - - - - .39 .07 -.01 .24 .46* .07 -.10 
6. Knowledge of treatments   - - - - - - .56** .15 .47* .26 .53** .33 
7. Knowledge of evaluation   - - - - - - - .17 .35 -.07 .29 .24       
8. Dialysis     - - - - - - - - .50* .33 .50* .06  
9. Health literacy     - - - - - - - - - .47* .35 .47*   
10. Medical mistrust    - - - - - - - - - - .23 -.08        
11. Navigators     - - - - - - - - - - - .21   
12. Instrumental support   - - - - - -           - - - - - - 
 
**p < .01; *p < .05.   
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Table 12 
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for Patients 
____________________________________________________________________________________________________________ 
      1 2 3 4 5 6 7 8 9 10 11 12   
 
1. Insurance status    -         .45* .47** .42* .16 .34 .29 .26 .21 -.08 .32 .40* 
2. Income     - - .46** .42* .34 .31 .24 .54** .46* .23 .13 .42* 
3. Distance to center     - - - .55** .17 .34 .26 .32 .39* .02 .45* .47**  
4. Comorbidities    - - - - .28 .43* .45* .48** .36 .12 .35 .34  
5. Religious beliefs    - - - - - .46* .37* .31 .12 .22 .11 .29 
6. Knowledge of treatments   - - - - - - .54** .63** .11 -.03 .39* .25 
7. Knowledge of evaluation   - - - - - - - .32 .51** -.04 .52** .60**       
8. Dialysis     - - - - - - - - .19 .19 .25 .21  
9. Health literacy     - - - - - - - - - .52** .65** .68**   
10. Medical mistrust    - - - - - - - - - - .43* .32        
11. Navigators     - - - - - - - - - - - .72**   
12. Instrumental support   - - - - - -           - - - - - - 
 
**p <  .01; *p < . 05.   
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Table 13 
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for all participants 
____________________________________________________________________________________________________________ 
      1 2 3 4 5 6 7 8 9 10 11 12   
 
1. Insurance status    -         .46** .23 .16 .09 .26 .20 .20 .21 -.08 .28* .30* 
2. Income     - - .53** .45** .29* .45** .40** .53** .49** .24 .30* .47** 
3. Distance to center     - - - .64** .28* .47** .42** .42** .42** .23 .45** .54**  
4. Comorbidities    - - - - .34* .53** .53** .45** .39** .12 .38** .47**  
5. Religious beliefs    - - - - - .50** .37** .28* .20 .33* .16 .29* 
6. Knowledge of treatments   - - - - - - .63** .58** .26 .15 .48** .42** 
7. Knowledge of evaluation   - - - - - - - .40** .53** .07 .52** .63**       
8. Dialysis     - - - - - - - - .33* .31* .38** .32*  
9. Health literacy     - - - - - - - - - .53** .62** .67**   
10. Medical mistrust    - - - - - - - - - - .42** .33*        
11. Navigators     - - - - - - - - - - - .67**   
12. Instrumental support   - - - - - -           - - - - - - 
 
**p <  .01; *p < . 05.   
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Test of Between Group Differences  
 To help address RQ9, Mann-Whitney U tests were conducted to examine differences 
between transplant professionals and patients in perception of barriers to completing the medical 
evaluation process. Transplant professionals (Md =48, n =23) reported significantly more 
perceived barriers than patients (Md =34.5, n =30), U = 133.50, z = -3.78, p= <.001, r = .52 (a 
large effect). Two Mann-Whitney U tests were used to examine participant (i.e. transplant 
professionals and patients) differences in perceived motivators. Specifically, navigators and 
instrumental support served as a positive impact on completing the medical evaluation process. 
The was no significant difference between transplant professionals’ (Md =6, n =23) and patients’ 
(Md =4.50, n =30), U = 281.50, z = -1.16, p= .25, perceptions of navigators as a positive impact 
on completing the medical evaluation process. In contrast, there was a significant difference 
between providers’ and patients’ perceptions of instrumental support as a positive impact on 
completing the medical evaluation process, U = 207, z = -2.56, p= .01. Specifically, transplant 
professionals (Md =6, n =23) reported instrumental support as having a greater positive impact 
on completing the medical evaluation process than did patients (Md =5, n =30). 
Discussion 
Renal patients experience a myriad of barriers throughout the medical evaluation process. 
The multitude of barriers can overwhelm attempts to finding solutions for overcoming these 
barriers. Categorizing and prioritizing factors that impact completion of the medical evaluation 
process is essential to helping African American patients proceed through the evaluation process 
and be listed for transplantation. The present study sought to determine the most important 
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factors that facilitate and/or impede progression through the medical evaluation by examining the 
perceptions of both transplant professionals and patients.  
Thematic analyses of both semi-structured interviews with transplant professionals and 
focus groups with patients revealed that renal patients going through the medical evaluation 
process are most impacted by barriers at the individual-level. Many of these barriers are socio-
economic (e.g., insurance issues, limited income, transportation difficulties and lack of social 
support). This finding corresponds with past literature which indicates that poor Black patients 
experience longer commutes to the transplant center, have less access to transportation, and those 
without good health insurance coverage are more likely to face barriers in attempts to seek 
kidney transplantation (Axelrod et al., 2010; Clark et al., 2008; Patzer et al., 2012). Concerns 
about finding a living donor and the costs associated with the evaluation were also reported to 
impact patients’ completion of the medical evaluation process. A recent study by Dageforde and 
colleagues (2015) reported synonymous findings as patients indicated concerns about their 
ability to find a living donor, and the costs of medications. Further, patients who reported 
transportation difficulties were less likely to complete their evaluation. Other types of individual-
level factors identified were lack of patient motivation, fears about losing disability benefits after 
transplantation, fears about the transplant surgery, religious beliefs and medical mistrust. Past 
research has also suggested that medical mistrust may be a contributing factor to the disparity 
between African Americans and other racial groups in access to kidney transplantation (Churak, 
2005; Moore, 2007).   
Transplant professionals and patients differed in the number of informational/educational 
barriers versus systemic barriers cited as impacting completion of the medical evaluation 
process. The next category of barriers most reported by transplant professionals were 
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informational/educational barriers. They identified barriers such as lack of knowledge about 
kidney transplantation, and more specifically lack of knowledge of the medical evaluation 
process as well as limited formation education. One explanation for patients’ limited knowledge 
of transplantation is that some patients first hear about transplantation from their doctors and 
nurses (Weng et al., 2005), particularly during their initial appointment for the pre-transplant 
workup. Patients’ lack of information about transplantation is well documented (Alexander & 
Sehgal, 1999; Navaneethan & Singh, 2006; Weng et al., 2005), even though dialysis centers are 
required to educate patients about transplantation annually (CMS, 2008). Gaps in formal 
education were also found to contribute to barriers in completing the medical evaluation in a 
study that compared Black and Whites referred for a pre-transplant workup (Patzer et al., 2012).  
Patients named systemic barriers as second in the likelihood to impact completion of the 
medical evaluation process. Specifically, they mentioned poor communication between the 
patients and transplant staff, scheduling difficulties, having to work with several doctors, long 
wait times for doctors’ appointments and test results, and not having access to the transplant 
coordinators as well as difficulties navigating the hospital system. Of note, the PI observed a 
disparity between some patients’ report of their activation status on the transplant list and what 
the transplant center indicated as their activation status – these patients believed they had 
completed their evaluation even though they had been listed as inactive, lending some support to 
patients’ report of poor communication with the transplant center. While it is possible that the 
status of some of the patients may have changed between the time in which the PI obtained the 
list of potential participants and actual participation in the study, other research confirms this 
finding (Gillespie, Hammer, Lee, Nnewihe, Gordon & Silva, 2011). Gillespie and colleagues 
revealed in a survey of hemodialysis patients undergoing the pre-transplant work-up that the 
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majority of these patients erroneously perceived themselves to be active on the waitlist whereas 
over half lacked knowledge of their status (Gillespie et al., 2011).   
Transplant professionals and patients also differed with regard to the third type of barrier 
to completing the medical evaluation process. Nephrologists, transplant coordinators, social 
workers, psychologists and a transplant nurse ranked systemic barriers as third, whereas patients 
reported health-related barriers as having the third most impact on progress to transplant 
candidacy. Similar to previous studies, delayed referral processes were cited by transplant 
professionals as contributing to this barrier (Alexander & Sehgal, 1999; Joshi et al., 2012). 
Health-related barriers reported by patients included health status (e.g., feeling physically sick or 
fatigued), not being cleared by psychiatry, and having multiple health conditions that required 
treatment prior to activation on the transplant waitlist. Comorbidities that increase the number of 
medical procedures required for clearance have been known to limit renal patients’ progression 
through the medical evaluation (Danovitch et al., 2004; Navaneethn & Singh, 2006).  
The fourth type of barrier identified by transplant professionals were health-related 
barriers. In contrast, patient identified informational/educational barriers. Patients expressed a 
need for information about the medical evaluation process, especially the number of tests 
involved and the financial aspects of getting a transplant. Notably, transplant professionals 
reported more barriers relative to patients. This could be attributed to the fact that transplant 
professionals have a broader view of some of the problems faced by patients given that they 
consult with several patients. However, in comparison to the majority of patients who have 
participated in the medical evaluation, the sample surveyed for the current study may have 
experienced fewer barriers. For example, the majority of the study participants lived within a 
twelve-mile radius of the transplant center and had access to transportation.  
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Motivators were also categorized, with transplant professionals’ identifying systemic 
motivators most frequently, followed by informational/educational motivators and individual-
level motivators. Specifically, transplant professionals indicated systemic motivators such as 
more referrals from local nephrologists, patient navigators, case management, physician rapport, 
compressed testing and comprehensive insurance. Informational/educational motivators 
consisted of center-based education, formal education, presenting information in lay terms, and 
education about transplantation to help improve completion rates. Individual-level motivators 
included patients’ desire to get off dialysis or have a better quality of life, religious beliefs that 
motivate patients, and knowledge of a successful recipient. Alternatively, patients identified 
individual-level motivators most frequently followed by systemic and informational/educational 
motivators. Individual-level motivators consisted of family support, financial support from 
family members, support from the transplant staff, and religious beliefs. Systemic motivators 
were good communication with the transplant coordinators, updates on the patient’s position on 
the transplant waitlist, and rehabilitation support for patients without family support. 
Informational and educational motivators included transplant education, having the transplant 
information geared to the patient’s understanding and knowledge of successful transplant 
recipients. Many of the motivators reported by patients and transplant professionals aligned with 
the extant literature. Specifically, social networks (especially instrumental support), previous 
knowledge of transplantation, information about the benefits of transplantation, comprehensive 
insurance, support from transplant staff and patient navigators have a positive impact on patients’ 
completion of the medical evaluation process (Clark et al., 2008; Dageforde et al., 2015; Sullivan 
et al., 2012; Weng et al., 2005). A surprising finding was that for the majority of patients in this 
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study, religious beliefs actually encouraged completion of the evaluation rather than imposing a 
barrier.  
Given the multitude of factors contributing to completion of the transplant medical 
evaluation, prioritization is critical to understanding the most important and potentially 
modifiable factors and identifying solutions for their remediation. Participant rankings of the top 
five barriers and motivators to completing the medical evaluation served this purpose. Patient 
and transplant professional similarly ranked insurances issues, low SES/limited income and lack 
of a personal means of transportation in their top five barriers to completing the medical 
evaluation process. Transplant professionals also ranked lack of patient motivation and the 
number of tests or medical procedures required to finish the medical evaluation process in their 
top five. Patients ranked scheduling difficulties and time constraints in trying to attend their 
medical appointments, dialysis, and participate in regular activities in their top five. The latter 
barriers are related to the number of tests required to complete the evaluation process since 
patients have to undergo several medical procedures to become active on the waitlist. Although, 
transplant professionals may perceive some patients as lacking in motivation, this could be 
attributed to a number of factors. For example, patient fears about losing their benefits after 
transplantation or fear of the transplant operation may lead to reduced motivation. Further, many 
renal patients are physically ill due to prolonged dialysis therapy or as a result of having several 
comorbidities. Hence, attending several medical appointments is bound to create additional 
strain, making patients appear less motivated. Transplant professionals may also fail to 
acknowledge the informational/educational and systemic barriers patients face which results in 
the perception of patients as lacking motivation.  
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Participants’ rankings of motivators were also prioritized with both transplant 
professionals and patients prioritizing social support and informational support. Transplant 
professionals ranked center-based education, patient’s knowledge of the benefits of 
transplantation over dialysis and patient navigators in their top five. In contrast, patients ranked a 
desire of get off dialysis, religious beliefs and support from the transplant staff in their top five. 
Together, improvements in transplant education, and additional services and support from the 
transplant center facilitate patient’s completion of the medical evaluation. Additional solutions to 
reducing the barriers faced by African American renal patients proposed by transplant 
professionals and patients include comprehensive insurance, financial assistance, assistance with 
fundraising, creating programs to motivate and empower patients, and continuous education 
throughout the medical evaluation process. Also, hearing the success stories of kidney recipients, 
kidney support groups, patient navigators, case management, good communication between the 
transplant staff and patients, and liaisons between the transplant center and dialysis center were 
suggested as solutions.    
This current study is the first to demonstrate the value of categorizing and prioritized the 
multitude of factors that impact completion of the medical evaluation process. The use of a focus 
group with a NGT to prioritize these factors was both innovative and pertinent to determining 
what is most beneficial for helping these population complete the pre-transplant work-up. 
Moreover, categorizing these barriers and motivators has the added value of improving 
researchers and providers’ understanding of their patients’ needs and will help target 
interventions. For example, improving center-based education for patients whose barriers are 
mostly health-related would likely have minimal benefit for improving their odds of completing 
the medical evaluation process. The current study indicates that African American patients are 
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faced with several barriers, many of which are the result of socioeconomic disadvantages. 
Categorizing barriers and motivators to completing the medical evaluation process is the first 
step in tackling the disparity in access to transplantation between African Americans and other 
racial groups. Additional resources such as financial assistance, fundraising, comprehensive 
insurance plans that include assistance with transportation, encouraging family engagement for 
instance, would likely enhance African American renal patients’ ability to complete the medical 
evaluation process. This study proposed a structure for categorizing factors that impact 
completion of the medical evaluation process by dividing barriers and motivators into individual-
level, systemic, informational/educational and health-related barriers and motivators. Creating a 
system that categorizes barriers and motivators to pre-transplant work-up completion better 
equips transplant centers for honing in on ways to help their African American patients complete 
their evaluation. The prioritization of the top barriers and motivators is also valuable for 
prioritizing patient needs.  
Strengths, Limitations and Future Studies 
 There are several strengths to the current study. This study provides a better 
understanding of the experience of African American renal patients. Although previous literature 
has identified several barriers and motivators to completing the medical evaluation process, no 
study to date has employed the nominal group technique to categorize and prioritize these 
factors. The current study provides a structure to help understand these factors in order to find 
solutions that will ultimately bring parity in access to kidney transplantation for African 
American patients. By gathering information from both transplant professionals and patients, this 
study provides the additional advantage of a broader understanding of the pre-transplant work 
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up. Furthermore, the use of a mixed methods approach provides a thorough form of analysis 
which extends the previous literature.   
 There are a number of limitations to this study. Given that snowballing was used as the 
main recruitment tool with the transplant professional sample, this may limit findings as those 
who agreed to participate may be motivated by a desire to know more about this topic. 
Additionally, with snowballing, information sharing may be restricted to in-group members 
reducing the diversification of participant responses. Future studies should implement an 
assortment of recruiting techniques to facilitate the generation of a variety of participant 
responses. Patients who participated in the study had to come to the study location. This is 
another limitation to the study given that one of the top five barriers to completing the medical 
evaluation is access to transportation. Therefore, the study sample may be biased since those who 
participated may actually have fewer barriers in comparison to the larger population of African 
American renal patients. Nonetheless, these participants were still able to list a substantial 
number of barriers, highlighting the magnitude of difficulties faced by all renal patients. Future 
studies should be conducted with a heterogeneous group of patients. A community-based 
research study in which the researchers conduct the study at a convenient location for patients 
would preferable. For example, at the transplant center during patients’ appointment, at a dialysis 
center or by making house calls. Another limitation is that participants who were more reserved 
in the focus groups may have felt limited in their ability to voice their opinions during the 
discussions, possibly limiting the emergence of alternative responses.  
Given that this study was able to generate a structure for categorizing patient barriers and 
motivators, future studies should develop a psychometrically-sound questionnaire that measures 
these barriers and motivators. Consequently, this could be used for additional exploration of this 
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phenomenon as well as used in transplant centers to assess possible barriers to completion of the 
medical evaluation process, and identify services needed to enhance patients’ ability to progress 
through the evaluation process to transplant candidacy. Such a tool would better equip transplant 
professionals to help patients overcome barriers to completion of the pre-transplant work up.  
Conclusion 
 The findings from the current study are useful for providing vital information to 
transplant centers nationally as it could help improve centers’ ability to meet the needs of all 
patients seeking transplantation, especially African American patients. In consulting with renal 
patients, it is recommended that transplant professionals attempt to assess barriers and 
motivators. For example, one participant indicated that her local nephrologist ordered some of 
the tests she needed for the medical evaluation prior to her initial appointment. As a result, the 
patient had completed many of the medical procedures before her appointment, making it easier 
to complete her evaluation. This is an example of simple process that can become standard 
procedure for the medical evaluation for kidney transplantation.  
These results from the current study could also inform intervention programs targeting 
African American renal patients’ ability to completion of the medical evaluation. For example, 
an intervention with kidney support groups could be implemented to determine its utility for 
helping improve completion rates. Given that religious beliefs were revealed as a facilitator of 
completion of the medical evaluation process, involving churches, faith communities and 
community organizations has the potential for boosting completion rates.  
The results of the current study also suggest that a change in the policy of patients losing 
their benefits, three years post-transplant is warranted. This policy creates an additional burden 
for renal patients, many of whom may have been out of the workforce for several years due to 
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their condition. Although they may be ready to join the workforce three years post-transplant, it 
may be an unrealistic expectation for all patients as a prolonged departure from the workforce 
may reduce job prospects and leave patients struggling to find work that pays enough to cover 
the cost of medications. Comprehensive insurance plans are also critical for renal patients given 
that some patients may be unable to afford co-pays, especially when they are required to undergo 
several medical procedures and may have to attend specialist appointments. Out-of-pocket costs 
associated with transplant such as paying for lodging to attend doctors’ appointments and 
transportation difficulties create an additional burden for patients. Currently, ESRD patients 
qualify for Medicare part A (Hospital insurance) and can also obtain part B (Medical insurance) 
which has a monthly premium. Both of these services facilitate a patient’s ability to obtain full 
benefits to cover the cost of certain renal replacement therapies (CMS, 2016). Specific to 
transportation, these services only cover ambulance services and do not cover doctor’s visits or 
trips to the dialysis center.  Patients with a Medicare part C (Medicare Advantage Plan) and 
those with Medicaid are the only ones eligible for coverage of non-emergency doctors’ visits. It 
may be beneficial to extend transportation services to all ESRD patients to reduce the 
transportation barriers faced by these patients. Further, patients should be supplied with 
information about national organizations such as the American Kidney Fund and fundraising 
tools when they initiate the medical evaluation process to expand their access to resources that 
can help reduce their financial barriers.  
In November 2013, the OPTN policy changed to allow patients with an inactive status to 
accrue time on the waitlist. It is unknown whether this change in policy will impact African 
American renal patients’ completion of the medical evaluation. Nonetheless, the information 
gathered from the current study could help inform systemic changes that would in turn narrow 
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the health disparities in access to kidney transplantation between African Americans and other 
racial groups. 
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Appendix A 
Transplant Professionals’ Interview Protocol 
Opening Script: 
Thank you for taking the time to speak with me today about your perceptions of the factors 
impacting the completion of the medical evaluation for renal patients seeking kidney 
transplantation. My name is Camilla Nonterah and I am a VCU counseling psychology doctoral 
candidate working on my dissertation research.  The purpose of this interview is to gather 
transplant professionals’ perceptions of the factors that facilitate and impede renal patients’ 
completion of the medical evaluation process for kidney transplantation. Please know that your 
opinions are appreciated and your honesty and experience working with renal patients is valued. 
The results of the interviews will be incorporated into the second part of my study which will 
examine the views of patients to have a better understanding of the medical evaluation process 
for this population. With your permission I would like to record this interview, your identity and 
what you say will be kept confidential.  Your name will not appear in the interview transcript or 
any summary reports.  The interview will last about 45-60 minutes. Do you have any questions 
before we begin?  
Experience: 
  
1. Please describe your experience working with ESRD patients seeking a transplant? [Probe: 
How long have you worked with this population? Overall, would you say that your experience 
with has been generally positive or negative? Why? What challenges have you faced in working 
with patients seeking kidney transplantation?]  
 
2. How has your experience differed when working with patients of different sexes (male versus 
female)? [Probe: That is, in what ways is it easier or more difficult to work with males as 
compared to females?] 
 
3. How has your experience differed when working with patients from different racial and/or 
ethnic backgrounds (for example, African American patients versus Caucasian patients)? 
[Probe: That is, in what ways is it easier or more difficult to work with African Americans as 
compared to Whites?] 
 
Medical Evaluation Process:  
4. Please describe the medical evaluation process at your transplant center? [Probe: What tests 
and/or medical procedures must patients undergo to be evaluated and listed for 
transplantation?]  
5. How long does it take the average patient to complete the evaluation process? [Probe: And, 
how long does it typically take for patients with multiple other health issues, in addition to renal 
failure, to complete the medical work up?] 
6. At what point in the evaluation are patients most likely to stop completing or drop out of the 
process?  
7. What challenges do patients at your center face in completing the medical evaluation for 
listing for kidney transplantation? [Probe: For example, perhaps insurance issues, the sheer 
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number of tests, or transportation difficulties interfere with patients’ ability to complete the 
evaluation? Anything else?] 
As you may already know, ethnic/racial disparities have been found in all aspects of 
transplantation, including patients’ completion of the medical evaluation process and 
subsequent listing for transplantation. While I’m interested in finding ways to improve the 
process and reduce barriers to completing the transplant evaluations for all patients, I’m 
particularly interested in reducing or eliminating these disparities. So, for the following 
questions, I will ask about potential barriers to completing the process that all patients may 
face; then, I will ask you to think specifically about barriers for Blacks/African American 
patients. 
Barriers:  
8. What individual-level factors impede patients’ completion of the evaluation process? [Probe: 
In your experience, have religious beliefs, medical mistrust, motivation, or some other factors 
kept patients from completing the process? NB: Write down individual-level factors mentioned 
by participant] 
9. What health-related factors keep patients from finishing the evaluation process? [Probe: In 
your experience, have the number or nature of any additional health issues prevented or 
impeded patients’ completion of the medical evaluation? NB: Write down health-related-level 
factors mentioned by participant]  
10. What system-level factors keep patients from finishing the evaluation process and being 
listed for transplantation? [Probe: That is, what problems in the healthcare system, such as the 
evaluation process itself or the lack of patient navigators, affect patients’ ability to complete the 
testing process? NB: Write down system-level factors mentioned by participant]  
 
11. What information or education-related factors keep patients from finishing the process? 
[Probe: In your experience, have patients’ limited knowledge of transplantation or the medical 
evaluation process impacted their completion of the evaluation? NB: Write down information 
or education-related factors mentioned by participant] 
 
So, we’ve now discussed a variety of potential barriers to patients’ successful completion of the 
medical evaluation and subsequent wait listing for kidney transplantation. 
12a. How do you think these barriers differ depending on the patient’s gender? [Probe: What 
factors, if any, are specific to women or specific to men (that is, they do not impede men but do 
limit women’s capacity to compete the evaluation or vice-versa)?]  
 
12b. How might these factors affect African American and Caucasian patients differently? 
[Probe: What factors, if any, are specific to African American patients (that is, they do not 
 103 
 
impede Caucasian patients but do limit African Americans’ capacity to compete the evaluation)? 
NB: Remind participant of individual, health, systemic, information list above if needed] 
 
The following questions focus solely on your experience working with Black/African 
American patients. Please answer Yes or No to each question.  
13a. In your experience, have Black patients’ income level impacted their ability to complete the 
medical evaluation process? [Probe for transportation difficulties, ability to pay for food or 
lodging] 
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question  
13b.  If yes, how? 
13c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (income level)? 
 
14a. Do you believe that the distance from the transplant center to a patient’s house impacts 
Black patients’ ability to complete the evaluation? [Probe for difficulties coming to appointments 
or finding lodging]  
0 □  No   
1    □  Yes 
2    □    Depends  
 
14b. If yes, in what way or ways? 
If no skip to next question  
14c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (distance from the transplant center to a patient’s house)? 
 
15a. Health literacy is defined as the degree to which individuals have the ability to obtain, 
process and understand basic health information and services in order to make appropriate 
health decisions. Do you think that health literacy has an impact on African American patients’ 
ability to complete the medical evaluation process?     
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question  
15b. If yes, how? 
15c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (health literacy)? 
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16a. Does knowledge about the different treatment options available impact Black patients’ 
ability to complete the medical evaluation process?   [Probe for lack of knowledge about the 
benefits of kidney transplantation] 
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question  
16b. If yes, how? 
16c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (knowledge about the different treatment options available)? 
 
 
17a. Does knowledge about the medical evaluation process, including the time it will take to 
complete all the necessary tests and the specific tests that will be conducted, impact African 
American patients’ ability to complete the process? [Probe for a lack of understanding of the 
process] 
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question  
17b. If yes, how? 
17c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (knowledge about the medical evaluation process)? 
 
18a. Do comorbidities (i.e., other illnesses in addition to ESRD) impact Black patients’ ability to 
complete the evaluation?   [Probe for an increase in the number of tests they need to complete] 
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question  
18b. If yes, how? 
18c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (comorbidities)? 
 
19a. In your experience, have religious beliefs impacted African American patients’ ability to 
complete the medical evaluation process? [Probe for beliefs regarding personal sacrifice, 
carrying personal burdens alone, or concerns about desecrating the body through 
transplantation] 
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question 
19b. If yes, how? 
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19c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (religious beliefs)? 
 
 
20a. Medical mistrust is defined as concerns about trust and discrimination in populations of 
patients with chronic illness. Do you believe that medical mistrust impacts Black patients’ ability 
to complete the process? [Probe for discrimination or perceived prejudice by health care 
providers]    
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question 
20b. If yes, how? 
20c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (medical mistrust)? 
 
 
21a. Navigators are individuals who educate patients and help them navigate through the 
medical system. Does the lack of patient navigators impact African American patients’ ability to 
complete the process?       
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question 
21b. If yes, how? 
21c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (navigators)? 
 
 
22a. Instrumental support networks are defined as the number of close friends or family that can 
help with daily activities at home. This means does the patient have people who help him/her 
with activities such as cooking, child care, scheduling appointments and transportation?  
Does instrumental support, or the lack thereof, impact African American patients’ ability to 
complete the medical evaluation process?        
0 □  No   
1    □  Yes 
2    □    Depends  
If no skip to next question 
22b. If yes, how? 
21c.  Are Blacks/African American patients more or less likely than White/Caucasian patients to 
be affected by this (instrumental support networks)? 
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Motivators:  
23. What factors motivate patients to complete the evaluation process? [Probe: What individual, 
systemic, health or information related factors motivate patients to complete the evaluation 
process?  
 
24. Please complete this statement. In my experience, the typical patient who completes the 
medical evaluation process is ………. [Probe: Those who complete the medical evaluation are 
typically of what gender, racial group, age etc?] 
 
Potential Solutions:   
25. In your opinion, what might be done to help patients overcome these barriers and complete 
the medical evaluation process?  
 
 
26. What would you recommend to help African American patients, specifically, complete the 
medical evaluation process and reduce disparities in this aspect of transplantation?    
 
Finally, as part of this project, I will compare transplant professionals’ rankings of the barriers 
and motivators to patients’ completion of the medical evaluation process to patients’ rankings. 
Please take a moment now to numerically rank the 5 most significant barriers and motivators 
from the following lists [from the list emailed to you at the start of this interview].  
 
Closing Script: 
Thank you for your time today. Here is a $5 Starbuck’s gift card as thanks for your time and 
participation. If you have any additional comments or questions about this research, please 
contact me, Camilla Nonterah, at nonterahcw@vcu.edu.  
Would you like a copy of the results when they are ready? 
0 □  Does not want results  
1    □  Wants results 
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Appendix B 
TRANSPLANT PROFESSIONALS SURVEY  
 
1. What is your race? 
 1  □  African American 
 2  □  Asian/Pacific Islander  
 3  □  Caucasian 
 4  □  American Indian/Alaskan 
 5  □  Mixed race (Specify:__________________________) 
 6  □  Other (Specify:______________________________) 
8  □  NR/NA 
 
2. Respondent’s gender:    
1 □  Male   
1    □  Female 
3. Occupation  
1  □  Nephrologist 
2  □  Transplant coordinator  
3  □  Social Worker 
4 □  Other (Specify:______________________________) 
 
4. What is the highest grade or degree you have completed?  _____________   (Grade/Degree) 
 1  □  High school or less  
 2  □  Associate’s degree 
 3  □  Some college, no degree  
 4  □  More than Associate’s degree, but no Bachelor’s degree 
 5  □  Bachelor’s degree 
 6  □  Some graduate school, no degree 
7 □  Master’s degree 
 8  □  Uncompleted graduate training beyond a Master’s degree 
9  □  Doctorate  
 88  □  NR/NA 
 
5. Years of experience working with transplant patients ________________? 
 
Please tell me how much you think the following impact the medical evaluation process  
 
6.  On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think an African American patient’s health insurance 
status impacts their ability to complete the medical evaluation process? 
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
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7. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5 
and 6 in between, how much do you think an African American patient’s income level impacts 
their ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
8. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5 
and 6 in between, how much do you think the distance from the transplant center to the patient’s 
house impacts an African American patient’s ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
9. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5 
and 6 in between, how much do you think comorbidities (i.e. a patient having other illness in 
addition to ESRD) impact an African American patient’s ability to complete the medical 
evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
10. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think an African American patient’s religious beliefs 
impacts their ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
11. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think an African American patient’s knowledge about 
different treatments impacts their ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
12. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, , how much do you think an African American patient’s knowledge about 
the medical evaluation process impacts their ability to complete the medical evaluation process?        
        
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
 
 
13. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, , how much does being on dialysis impact an African American patient’s 
ability to complete the medical evaluation process?        
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   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
 
14. Health literacy is defined as the degree to which individuals have the ability to obtain, 
process and understand basic health information and services in order to make appropriate 
health decisions. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly 
impacts” with 2, 3, 4, 5 and 6 in between, how much do you think health literacy impacts an 
African American patient’s ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
15. Medical mistrust is defined as concerns about trust and discrimination in populations of 
patients with chronic illness. On a scale from 1 to 7, with 1 being “Not at all” and 7 being 
“Strongly impacts” with 2, 3, 4, 5 and 6 in between, how much do you think medical mistrust 
impacts an African American patient’s ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
16. Navigators are individuals who educate patients and help them navigate through the medical 
system. On a scale from 1 to 7, with 1 being “No impact” and 7 being “Extremely positive 
impact” with 2, 3, 4, 5 and 6 in between, how much would navigators impact an African 
American patient’s ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        No at      all Extremely positive impact  
17. Instrumental support networks are defined as the number of close friends or family that can 
help with daily activities at home. On a scale from 1 to 7, with 1 being “No impact” and 7 being 
“Extremely positive impact” with 2, 3, 4, 5 and 6 in between, how much would instrument 
support impact an African American patient’s ability to complete the medical evaluation 
process?        
 
   1 2 3 4 5 6 7 
        Not at       all Extremely positive impacts 
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Appendix C 
ESRD Patients Nominal Focus group (Status 1 &2) Protocol 
 
I. Introduction 
Thank you all for coming today/tonight. My name is Camilla Nonterah and I am a counseling 
psychology doctoral student at VCU. Assisting me today is __________. Thank you for agreeing 
to participate in this study. The information you provide will be very useful in helping us 
understand the factors which impact the completion of the medical evaluation process for end 
stage renal disease (ESRD) patients.  
 
II. Description of Focus Group:  
To begin, I would like to give you an overview of how this focus group will work. As you know, 
the focus group will last for about 45 minutes to 1 hour. During this time period, I will ask you 
some questions about your experience as a patient with end stage renal disease (ESRD). While I 
encourage you to draw on your experience, we do not need to know the details of your medical 
history or specific visits. The goal is for you to discuss the questions as a group. The most 
important information will come from the range of everyone’s thoughts and ideas. It is very 
important that everyone speaks their mind and participates, particularly if you have a different 
perspective from others in the group. There are no “right” or “wrong” answers to the questions. 
We are interested in the full range of perspectives. 
 
My role is to help facilitate the discussion of this topic. I may ask specific individuals about their 
thoughts or ideas if they have not had a chance to participate very much in the discussion. I also 
may have to interrupt someone to ask that we get everyone’s opinion or to move on to another 
topic. This is to ensure that we get everyone’s views on all the questions in the relatively short 
time we have together.  
 
Another important ground rule for this meeting is that we will respect the privacy of all group 
members and keep the content of our discussion confidential. We will call each other only by 
first names, and your verbal and written comments will be kept strictly confidential. I will be 
audiotaping the discussion, and you may see me taking notes. These steps are necessary for us to 
accurately record what is said today/tonight, but we will not include any information that will 
personally identify you in our notes or recordings. At any point in time, you are free to stop 
participating in the discussion or even leave. When we analyze our notes from this discussion, 
we will be most interested in what the group as a whole has to say. After we complete the 
analysis, we will erase and throw away the tape recording. When we publish the results of our 
study, no individuals will be identified. Finally, please remember that located on your consent 
form are the names and numbers of people you can call in future if you have questions about 
your rights as a research participant. 
Does anyone have any questions? [Answer any questions] 
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III. Warm up [7 minutes] 
Before moving on to the main topic of our discussion, I would like to take a few moments for 
everyone to introduce himself/herself. Specifically, I would like everyone to tell us their first 
name (you can also choose a pseudonym) and briefly tell us what their hobbies or interests are.  
 
Let me begin…. 
[Moderator: Introduces herself/himself and then goes around the table.] 
[Moderators Assistant: Will take notes on where particular people are sitting by creating a 
diagram similar to the room and focus group layout. Individual first names will then be 
associated with a numbered position in the diagram. These numbers make it possible to follow 
more accurately who in the group is speaking when listening to the tapes again as well as 
confidentially matching forms completed during the focus group with names.] 
 
______________________________________________________________________________ 
TOPIC 1:  INTRODUCTION  
1. What made you interested in participating in this study? [Probe: Are you interested in the 
topic? Are you looking for answers? Are you hoping that your participation will help 
others?] 
 
TOPIC 2: ESRD EXPERIENCE  
2. Describe your experience so far as a patient with kidney disease? [Probe: What 
challenges have you faced as a patient with ESRD?] 
 
TOPIC 3: MEDICAL EVALUATION EXPERIENCE  
3. What information have you been given about the medical evaluation process? [Probe: 
Were you provided with information about the evaluation process itself and the number 
of tests you would have to take for instance? Were you given with information about the 
risks and benefits of kidney transplantation? Were you given information about what will 
happen after transplantation?] 
 
What information would have been helpful? [Probe: Would you have liked additional 
information about the evaluation process such as the number of tests you have to take, 
possible insurance issues, the importance of having others who could support you 
through the process?] 
 
4. Where are you in the medical evaluation process? [Probe: Have you completed the 
process and all necessary requirements?]  
 
5. What tests did you have to complete? [Probe: That is have you finished the basic blood 
work and initial testing? What tests are you yet to complete?] 
 
6. What was it like for you to go through the medical evaluation process? [Probe: Overall, 
would you say that your experience with has been generally positive or negative? Why? 
Are there certain things which have been particularly difficult?] 
 
TOPIC 4: MOTIVATORS TO COMPLETING THE MEDICAL EVALUATION   
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7. What are some things which made it easier to complete the medical evaluation process 
for kidney transplantation? [Probe: For example, did having the support of your family, 
the transplant staff or being educated about the evaluation process make it easier to 
complete the medical evaluation process? Anything else?] 
 
8. Now I’ll like you to list the 5 most important things (on the post it you’ve been provided) 
which helped you complete the medical evaluation process. Place rankings beside the 
motivators you’ve listed (with 1 being the most significant motivator, followed by 2 and 
so on) [Probe: group members to list top 5 motivators and build a hierarchy] 
 
TOPIC 5: BARRIERS TO COMPLETING THE MEDICAL EVALUATION   
 
9. What are some things which made it difficult to complete the medical evaluation 
process? [Probe: For example, perhaps insurance issues, the sheer number of tests, or 
transportation difficulties, additional health problems, not having close friends or family 
for support interfered with your ability to complete the evaluation? Anything else?]] 
 
 
10. Now I’ll like you to list the 5 most important barriers (on the post it you’ve been 
provided) which made it difficult to complete the medical evaluation process. Place 
rankings beside the barriers you’ve listed (with 1 being the most significant barrier, 
followed by 2 and so on) [Probe: group members to list top 5 barriers and build a 
hierarchy] 
 
IV.   CLOSING:   
 
Option 1:  Time Still Remaining:  Before we end the session, are there any other comments that 
you have or topics that we missed in our discussion?  Thank you for your time and participation. 
Option 2: Time is Up:  If, after today’s session, you think of any other comments or topics that 
were missed please feel free to contact me (e.g., focus group facilitator) by email.  Thank you for 
your time and participation. 
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Appendix D 
 
ESRD Patients Nominal Focus group (Status 7) Protocol 
I. Introduction 
Thank you all for coming today/tonight. My name is Camilla Nonterah and I am a counseling 
psychology doctoral student at VCU. Assisting me today is __________, Thank you for agreeing 
to participate in this study. The information you provide will be very useful in helping us 
understand the factors which impact the completion of the medical evaluation process for end 
stage renal disease (ESRD) patients. 
  
II. Description of Focus Group:  
To begin, I would like to give you an overview of how this focus group will work. As you know, 
the focus group will last for about 45 minutes to 1 hour. During this time period, I will ask you 
some questions about your experience as a patient with end stage renal disease (ESRD). While I 
encourage you to draw on your experience, we do not need to know the details of your medical 
history or specific visits. The goal is for you to discuss the questions as a group. The most 
important information will come from the range of everyone’s thoughts and ideas. It is very 
important that everyone speaks their mind and participates, particularly if you have a different 
perspective from others in the group. There are no “right” or “wrong” answers to the questions. 
We are interested in the full range of perspectives. 
 
My role is to help facilitate the discussion of this topic. I may ask specific individuals about their 
thoughts or ideas if they have not had a chance to participate very much in the discussion. I also 
may have to interrupt someone to ask that we get everyone’s opinion or to move on to another 
topic. This is to ensure that we get everyone’s views on all the questions in the relatively short 
time we have together.  
 
Another important ground rule for this meeting is that we will respect the privacy of all group 
members and keep the content of our discussion confidential. We will call each other only by 
first names, and your verbal and written comments will be kept strictly confidential. I will be 
audiotaping the discussion, and you may see me taking notes. These steps are necessary for us to 
accurately record what is said today/tonight, but we will not include any information that will 
personally identify you in our notes or recordings. At any point in time, you are free to stop 
participating in the discussion or even leave. When we analyze our notes from this discussion, 
we will be most interested in what the group as a whole has to say. After we complete the 
analysis, we will erase and throw away the tape recording. When we publish the results of our 
study, no individuals will be identified. Finally, please remember that located on your consent 
form are the names and numbers of people you can call in future if you have questions about 
your rights as a research participant. 
 
Does anyone have any questions? [Answer any questions] 
III. Warm up [7 minutes] 
Before moving on to the main topic of our discussion, I would like to take a few moments for 
everyone to introduce himself/herself. Specifically, I would like everyone to tell us their first 
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name (you can also choose a pseudonym) and briefly tell us what their hobbies or interests are. 
Let me begin…. 
[Moderator: Introduces herself/himself and then goes around the table.] 
[Moderators Assistant: Will take notes on where particular people are sitting by creating a 
diagram similar to the room and focus group layout. Individual first names will then be 
associated with a numbered position in the diagram. These numbers make it possible to follow 
more accurately who in the group is speaking when listening to the tapes again as well as 
confidentially matching forms completed during the focus group with names.] 
 
______________________________________________________________________________ 
TOPIC 1:  INTRODUCTION  
1. What made you interested in participating in this study? [Probe: Are you interested in the 
topic? Are you looking for answers? Are you hoping that your participation will help 
others?] 
 
TOPIC 2: ESRD EXPERIENCE  
2. Describe your experience so far as a patient with kidney disease? [Probe: What 
challenges have you faced as a patient with ESRD?] 
 
TOPIC 3: MEDICAL EVALUATION EXPERIENCE  
3. What information have you been given about the medical evaluation process? [Probe:: 
Were you provided with information about the evaluation process itself and the number 
of tests you would have to take for instance? Were you given with information about the 
risks and benefits of kidney transplantation? Were you given information about what will 
happen after transplantation?] 
 
4. What information would have been helpful? [Probe: Would you have liked additional 
information about the evaluation process such as the number of tests you have to take, 
possible insurance issues, the importance of having others who could support you 
through the process?] 
 
5. Have you started the medical evaluation process? [Probe: When did you start the 
process?  What do you have left to finish?] 
 
6. What tests have you done so far and what are you left to complete? [Probe: That is have 
you finished the basic blood work and initial testing? What tests are you yet to 
complete?] 
 
7. What has it been like for you going through the medical evaluation process? [Probe: 
Overall, would you say that your experience with has been generally positive or 
negative? Why? Are there certain things which have been particularly difficult?] 
 
TOPIC 4: BARRIERS TO COMPLETING THE MEDICAL EVALUATION   
8. What things make it difficult to complete the medical evaluation process? [Probe: For 
example, perhaps insurance issues, the sheer number of tests, or transportation 
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difficulties, additional health problems, not having close friends or family for support 
interfered with your ability to complete the evaluation? Anything else?]] 
 
9. Now I’ll like you to list the 5 most important barriers (on the post it you’ve been 
provided) which made/ have made it difficult to complete the medical evaluation process. 
Place rankings beside the barriers you’ve listed (with 1 being the most significant barrier, 
followed by 2 and so on) [Probe: group members to list top 5 barriers and build a 
hierarchy] 
 
 
TOPIC 5: MOTIVATORS TO COMPLETING THE MEDICAL EVALUATION   
 
10. What do you think will help you complete the medical evaluation process for kidney 
transplantation? [Probe: For example, will mobile testing, patient navigators, knowledge 
about kidney transplantation, more education about the medical evaluation help you 
complete the evaluation process?] 
 
11. Let’s rank order the most important things which will help you complete the medical 
evaluation process (with 1 being the most significant, followed by 2 and so on) explain 
why you chose these rankings [Probe: for group discussion where group members list 
top 5 barriers, build a hierarchy] 
 
IV.   CLOSING:   
Option 1:  Time Still Remaining:  Before we end the session, are there any other comments that 
you have or topics that we missed in our discussion?  Thank you for your time and participation. 
Option 2: Time is Up:  If, after today’s session, you think of any other comments or topics that 
were missed please feel free to contact me (e.g., focus group facilitator) by email.  Thank you for 
your time and participation. 
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Appendix E 
NOMINAL FOCUS GROUP SURVEY  
 
1. What is your race? 
 1  □  African American 
 2  □  Asian/Pacific Islander  
 3  □  Caucasian 
 4  □  American Indian/Alaskan 
 5  □  Mixed race (Specify:__________________________) 
 6  □  Other (Specify:______________________________) 
9  □  NR/NA 
 
2. Respondent’s gender:    
1  □  Male   
2  □  Female 
 
3.  What is your age? _______________(years) 
 
 
 
4. What is the highest grade or degree you have completed?  _____________   (Grade/Degree) 
 1  □  High school or less  
 2  □  Associate’s degree 
 3  □  Some college, no degree  
 4  □  More than Associate’s degree, but no Bachelor’s degree 
 5  □  Bachelor’s degree 
 6  □  Some graduate school, no degree 
7 □  Master’s degree 
 8  □  Uncompleted graduate training beyond a Master’s degree 
9  □  Doctorate  
 88  □  NR/NA 
 
5. What is your marital status?  
 1  □  Single/never married 
 2  □  Married/cohabit 
 3  □  Divorced 
 4  □  Separated 
 5  □  Widowed 
 8 □  NR/NA 
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6. What is your religion? 
 1  □  Atheist 
 2  □  Protestant  
 3  □  Catholic 
 4  □  Jewish 
 5  □  Mormon 
 6  □  Muslim 
 7  □   Greek/Russian Orthodox 
  8  □  Other (SPECIFY: _______________________________) 
 88  □  NR/NA 
 
7. What is your annual household income? 
 1  □  $0 – 19,999 (<$20,000) 
 2  □  $20,000 – 39,999 (<$40,000) 
 3  □  $40,000 – 59,999 (<$60,000) 
 4  □  $60,000 – 79,999 (<$80,000) 
 5  □  $80,000 – 99,999 (<$100,000) 
 6 □ $100,000 + 
 99 □ DON’T KNOW 
 88  □ NR/NA 
 
8. Have you completed the medical evaluation to be waitlisted for a kidney? 
1  □  Yes   
2  □  No  
 
8a. If yes, how long did it take you to complete the process? 
_______________(months/years) 
8b. If no, how long have you been undergoing the medical evaluation process?  
_______________(months/years) 
 
 
9.  Do you have health insurance? 
1  □  Yes   
2  □  No  
 
10. How far are you from the transplant center? ______________ (Distance in miles) 
 
 
 
11. Do you have the appropriate transportation to attend all your doctors’ appointments? 
1  □  Yes   
2  □  No  
3  □  Other: Please explain __________________________ 
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Please tell me how much you think the following impact the medical evaluation process  
 
12.  On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think your insurance status impact your ability to 
complete the medical evaluation process? 
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
13. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think your income level (i.e. your annual income) impacts 
your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
14.  On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think the distance from the transplant center to the 
patient’s house impacts your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
15. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think comorbidities (i.e. a patient having other illness in 
addition to ESRD) impacts your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
16. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think your religious beliefs impact your ability to 
complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
17. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, how much do you think your knowledge about different treatments impacts 
your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
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18. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 
5 and 6 in between, , how much do you think your knowledge about the medical evaluation 
process impacts your ability to complete the medical evaluation process?        
        
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
 
19. Health literacy is defined as the degree to which individuals have the ability to obtain, 
process and understand basic health information and services in order to make appropriate 
health decisions. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly 
impacts” with 2, 3, 4, 5 and 6 in between, how much do you think health literacy impacts your 
ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
20. Medical mistrust is defined as concerns about trust and discrimination in populations of 
patients with chronic illness. On a scale from 1 to 7, with 1 being “Not at all” and 7 being 
“Strongly impacts” with 2, 3, 4, 5 and 6 in between, how much do you think medical mistrust 
impacts your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Strongly impacts 
 
21. Navigators are individuals who educate patients and help them navigate through the medical 
system. On a scale from 1 to 7, with 1 being “No impact” and 7 being “Extremely positive 
impact” with 2, 3, 4, 5 and 6 in between, how much would navigators impact your ability to 
complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Extremely positive impact  
 
22. Instrumental support networks are defined as the number of close friends or family that can 
help with daily activities at home. On a scale from 1 to 7, with 1 being “No impact” and 7 being 
“Extremely positive impact” with 2, 3, 4, 5 and 6 in between, how much would instrumental 
support impact your ability to complete the medical evaluation process?        
 
   1 2 3 4 5 6 7 
        Not at       all Extremely positive impacts 
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